Advanced search
Publication Cover
Journal of Microencapsulation
Micro and Nano Carriers
Volume 7, 1990 - Issue 1
Submit an article Journal homepage
7
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 129-154 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Microvoltammetric measurements in a single microcapsule. ABE, T., MATSUE, T., and UCHIDA, I. Chem. Lett., 1989, (2), 301–304.
  • Covalent modification of serum transferrin with phospholipid and incorporation into liposomal membranes. AFZELIUS, P., DEMANT, E. J., HANSEN, G. H., and JENSEN, P. B. Biochim. Biophys. Acta, 1989, 979, (2), 231–238.
  • Further studies of Mycoplasma gallisepticum serum plate agglutination antigen grown in medium with artificial liposomes substituting for serum. AHMAD, I., KLEVEN, S. H., GLISSON, J. R., and AVAKIAN, A. P. Avian Dis., 1989, 33, (1), 140–149.
  • The investigation of the cytochrome P-450 interaction with the pyrene-labeled phosphatidylcholine and phosphatidylglycerol in sodium cholate micelles and proteoliposomes. AKHREM, A. A., ROMANOV, S. L., SKORNYAKOVA, T. G., KISEL, M. A., and KISELEV, P. A. Biol. Membr., 1988, 5, (10), 1061–1066.
  • Preparation and pharmacokinetics of biomaterial-doxorubicin. Erythrocyte ghosts and biovesicles. AL-Acm, A. J., Northeast University, Boston, MA, USA, Dissertation, 1988, 227 pp.
  • Effect of free intracellular calcium on the deformability of human erythrocyte ghosts resealed with a calcium buffer. AL-GAILANI, B. T., and COTTERRELL, D. Meeting of the Physiological Society, Paris, France, July 1–2. 1988. J. Physiol. Lond., 1988, 406, 227p.
  • Lipid-amino acid interactions. A study of tryptophan effects on dipalmitoyl-phosphatidylcholine multilamellar liposomes. ALBERTINI, G., BERTOLI, E., CURATOLA, A., G., MARIANI, P., RUSTICHELLI, F., and ZOLESE, G. Chem. Phys. Lipids, 1989, 50, (2), 143–154.
  • Some structural and dynamical properties of multilamellar vesicles incorporated with propranolol. ALBERTINI, G., DONATI, C., RUSTICHELLI, F., and PHADKE, R. S. Nuovo Cimento Soc. Ital. Fis., D, 1988, 10D, (11), 1399–1408.
  • Liposome-bound cyclosporine: retinal toxicity after intravitreal injection. ALGHADYAN, A. A., PEYMAN, G. A., KHOOBEHI, B., and Liu, K. R. Int. Ophthalmol., 1988, 12, (2), 105–107.
  • Liposome-bound cyclosporine: clearance after intravitreal injection. ALGHADYAN, A. A., PEYMAN, G. A., KHOOBEHI, B., MILNER, S., and Liu, K. R. Int. Ophthalmol., 1988, 12, (2), 109–112.
  • Liposome-bound cyclosporine: aqueous and vitreous level after subconjunctival injection. ALGHADYAN, A. A., PEYMAN, G. A., KHOOBEHI, B., MILNER, S., and Liu, K. R. Int. Ophthalmol., 1988, 12, (2), 101–104.
  • Stealth liposomes avoiding reticuloendothelial uptake. ALLEN, T. M. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer, Lake Tahoe, California, USA, February 16–20. 1988, 480 p. A. R. Liss, New York, NY, USA, publ. 1989, pp. 405–416.
  • Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. ALLEN, T. M., HANSEN, C., and RUTLEDGE, J. Biochim. Biophys. Acta, 1989, 981, (1), 27–35.
  • Effect of carbohydrates and glycerol on the stability and surface properties of lyophilized liposomes. ALoNso-RomANowssi, S., BioNni, A. C., and DISALVO, E. A. J. Membr. Biol., 1989, 108, (1), 1–11.
  • The transport of microspheres from the gastrointestinal tract to inflammatory air pouches in the rat. ALPAR, H. 0., FIELD, W. N., HYDE, R., and LEWIS, D. A. J. Pharm. Pharmacol., 1989, 41, (3), 194–196.
  • Effect of tubocurarine enclosed in liposomes on the EEG of experimental animals. ALYAUTDIN, R. N., and FILIPPOV, V. I. Farmakol. Toksikol. (Moscow), 1989, 52, (1), 20–23.
  • A method of calculating the liposome membrane permeability using dialysis method. AMBARTSUMIAN, T. G., ADAMIAN, S Ta, MARIKIAN, G. G., and PETROSIAN, L. S. Biofizika, 1989, 34, (1), 54–56.
  • IL-2 liposomes as an immunologic adjuvant. ANDERSON, P. M., OCHOA, A. C., and ESTRADA, J. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. Faseb. Fed. Am. Soc. Exp. Biol. J., 1989, 3, (3), A318.
  • Interaction of basic extension peptide fragments of adrenodoxin precursor with phospholipid vesicles. AOYAGI, H., LEE, S., NAKAMURA, H., PARK, N. G., and KATO, T. Int. J. Pept. Protein Res., 1988, 32, (5), 406–414.
  • Transmucosal passage of poly(alkyl cyanoacrylate) nanocapsules in the dog small intestine. APRAHAMIAN, M., MICHEL, C., HUMBERT, W., DEVISSAGUET, J. P., and DAMGE, C. Proceedings of the European Congress of Biopharmaceutical and Pharmacokinetics, 3rd, 1987, Imps. Univ. Clermont-Ferrand, Clermont-Ferrand, Fr., 187–192. Eds: Aiche, J. M. and Hirtz, J.
  • Interactions between aminoglycosides and phospholipids using liposomes: a possible mechanism of nephrotoxicity. ARAMAKI, Y., and TSUCHIYA, S. Pharm. Res. (NY), 1989, 6, (53), 362–366.
  • Kinetic and mechanical descriptions of the znicroencapsulated acrylate imaging process. ARNEY, J. S. J. Imaging Sci., 1989, 33, (1), 1–6.
  • Reduction of amino groups and changes of the surface charge of liposomes on methylation and peroxidation. ARNHOLD, J., HEROLD, W., ARNOLD, K., and DE.Ev, A. I. Stud. Biophys., 1989, 128, (1), 45–50.
  • Exclusion of PEG from membrane surfaces and aggregation of liposomes and lipoproteins. ARNOLD, K., ZSCHOERNIG, 0., PRATSCH, L., DONATH, E., BARTHEL, D., and HERRMANN, A. Stud. Biophys., 1988, 127, (1-3), 113–120.
  • Preparation of microspheres and microcapsules by interfacial polycondensation techniques. ASHADY, R. J. Microencapsulation, 1989, 6, (1), 13–28.
  • Preparation of nano- and microspheres by polycondensation techniques. ARSHADY, R. J. Microencapsul., 1989, 6, (1), 1–12.
  • In vitro transfer of apolipoproteins between HDL and artificial lipid particles. ASAMI, H., IRIYAMA, K., ToNoucm, H., MIICA, C., KIHATA, M., NISHIWAKI, H., and Sumac', H. Nippon Jomyaku, Keicho Eiyo Kenkyukaishi, 1989, 4, 308–311.
  • Tobramycin liposomes enmeshed in fibrin: Topical treatment of pseudomonas keratitis. ASSIL, K., FRUCHT-PERY, J., SCHNEIDERMAN, T., ZIEGLER, E., BROWN, S., DOUGLAS, H., and WEINREB, R. N. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual. Sci., 1989, 30, (3, Suppl.), 422.
  • Aggregation of cardiolipin liposomes induced by monovalent cations. ATsAconTsiAN, A. Z., VASIUKOV, A. E., PALANICER, D. V., and NADZHARIAN, G. N. Biofizika, 1989, 34, (1), 49–53.
  • Microspheric bodies for use in screening therapies for Alzheimer's disease and related conditions. US Patent-4816416; March 28, 1989. AVERBACH, P. Off. Gaz. US Pat. Trademark off. Pat. 1989, 1100, (4), 2411.
  • Development of microencapsulated DNBM quaternary ammonium inhibitors for paints. BAILIN, L. J., and AGARWALA, V. S. Tech. Rep. AFWAL-TR (US, Air Force Wright Aeronaut Lab), 1987, 2, Proc. Tri-Serv. Conf. Corros., 1987, 111–127.
  • Effect of the asymmetric calcium distribution on the bilayer properties of phosphatidylcholine-sonicated vesicles. BAKAS, L. S., and DISALVO, E. A. Biochim. Biophys. Acta, 1989, 979, (3), 352–360.
  • Microencapsulated microorganisms and proteins for soil and phylloplane agricultural applications. BAKER, C. A., BROOKS, A. A., and HENIS, J. M. S. 197th American Chemical Society National Meeting, Dallas, Texas, USA, April 9–14. 1989. Abstr. Pap. Am. Chem. Soc., 1989, 197, BTEC 7.
  • Liposome-encapsulated ampicillin or muramyl dipeptide against Listens monocytogenes in vivo and in vitro. BAKKER-WOUDENBERG, I. A. J. M., LOKERSE, A. F., VINK, J. C., and ROERDINK, F. H. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988. 480 p. A. R. Liss, New York, NY, USA, publ. 1989, pp. 275–286.
  • The role of secondary messengers in the regulation of lipid peroxidation in rat liver microsomes. BALDENKOV, G. N., SERBINOVA, E. A., BAKALOVA, R, A., TKACHUK, V. A., KAGAN, V. E., and STOYTCHEV, Ts S. Free Radic. Res. Commun., 1988, 4, (5), 277–281.
  • Monoclonal antibody-labeled liposomes can specifically target human small cell carcinoma of the lung xenografts in nude mice. BALL, E. D., OLDS, G. R., FANGER, M. W., LAU, J. R., and GEHO, W. B. National Meeting of the American Society for Clinical Investigation, Washington, D.C., USA, April 28-May 1, 1989. Clin. Res., 1989, 37, (2), 575A.
  • New high-performance liquid chromatography-based methodology for monitoring the conformational transitions of self-associating hydrophobic peptides, incorporated into liposomes. BANO, M. C., BRACO, L., and ABAD, C. J. Chromatogr., 1988, 458, 105–116.
  • RES targeting of 1,25-dihydroxyvitamin D-3 via microencapsulation. BAR-SHAVIT, Z., Auktou, R., GLYCK, D., SURY, V., and BEN-SASSON, S. European Symposium on Calcified Tissues, Jerusalem, Israel, March 12–16. 1989. Calif. Tissue Int., 1989, 44, (Suppl.), S12.
  • Relation between individual and ensemble release kinetics of indomethacim from microspheres. BENITA, S., BABAY, D., HOFFMAN, A., and Dommow, M. Pharm. Res., 1988, 5, (3), 178–182.
  • Glycoprotein IV incorporated into liposomes binds thrombospondin. BERK, G. I., Ascii, A. S., SCOTTO, A. W., and SILVERSTEIN, R. L., NACHMAN, R. L. National Meeting of the American Federation for Clinical Research, Washington, D.C., USA, April 28-May 1, 1989. Clin. Res., 1989, 37, (2), 377A.
  • Correlation of partitioning of nitroimidazoles in the n-octanol-saline, and liposome systems with pharmacokinetic parameters and quantitative structure-activity relationships (QSAR). BETAGERI, G. V., and ROGERS, J. A. Pharm. Res. (N Y ), 1989, 6, (53), 399–403.
  • Preparation of biodegradable poly( + I -)lactide microparticles using a spray-drying technique. BODMEIER, R., and CFIEN, H. G. J. Pharm. Pharmacol., 1988, 40, (11), 754–757.
  • The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. BODMEIER, R., and MCGINITY, J. W. Pharm. Res., 1987,4, (6), 465–471.
  • Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation method. III. Morphology of the microspheres during dissolution studies. BODMEIER, R., and MCGINITY, J. W. J. Microencapsul., 1988, 5, (4), 325–330.
  • The effect of the addition of low-molecular weight poly(DL-lactide) on drug delivery systems. BODMEIER, R., On, K. H., and CHEN, H. Int. J. Pharm., 1989, 51, (1), 1–8.
  • Microcapsules: preparation and control. BOGATAJ, M., KRISTL, A., MRHAR, A., and KOZJEK, F. Farm. Vestn. (Ljubljana), 1988, 39, (4), 239–252.
  • Lectin-bearing liposomes: differential binding to normal and to transformed mouse fibroblasts. BOGDANOV, A. A. Jr, GORDEEVA, L. V., TORCHILIN, V. P., and MARGOLIS, L. B. Exp. Cell. Res., 1989, 181, (2), 362–374.
  • Hemoglobin liposomes as blood replacement fluid. BRANDL, M., BECKER, D., and BAUER, K. H. Drug. Dev. Ind. Pharm., 1989, 15, (5), 655–669.
  • Stability and fusion of lipid vesicles containing headgroup-modified analogues of phosphatidylethanolamine. BROWN, P. M., and SiLvius, J. R. Biochim. Biophys. Acta, 1989, 980, (2), 181–190.
  • Using liposomes for the correction of respiratory hypoxia in experimental pneumonia. BRYGINSKII, S. A., ZUBARENKO, A. V., LISHKO, V. K., MINYAILENKO, T. D., POZHAROV, V. P., ROZOVA, E. V., SEREDENKO, M. M., and STEFANOV, A. V. Byull. Eksp. Biol. Med., 1988, 106, (10), 421–423.
  • A new cytochemical method for ultrastructural detection of liposomes in tissues in vivo. BUGELSKI, P. J., GENNARO, D. E., POSTE, G., and HOFFSTEIN, S. T. J. Histochem. Cytochem., 1989, 37, (6), 843–851.
  • Role of nucleotides in potassium chloride co-transport in resealed human erythrocyte ghosts. BURNSON, B., and O'NEILL, W. C. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (3), A580.
  • Secondary structure of diphtheria toxin and its. fragments interacting with acidic liposomes studied by polarized infrared spectroscopy. CABIAUX, V., BRASSEUR, R., WATTIEZ, R., FALMAGNE, P., RUYSSCHAERT, J. M., and GOORMAGHTIGH, E. J. Biol. Chem., 1989, 264, (9), 4928–4938.
  • Secondary structure changes of diphtheria toxin interacting with asolectin liposomes: an infrared spectroscopy study. CABIAUX, V., GOORMAGHTIGH, E., WATTIEZ, R., FALMAGNE, P., and RUYSSCHAERT, J. M. Biochimie, 1989, 71, (1), 153–158.
  • A simple method for reconstitution of CHO cell and human fibroblast acyl coenzyme A: cholesterol acyltransferase activity into liposomes. CADIGAN, K. M., and CHANG, T. Y. J. Lipid. Res., 1988, 29, (12), 1683–1692.
  • Xenotransplantation of microencapsulated canine islets in diabetic mice. CALAFIORE, R., CALCINARO, F., BASTA, G., PIETROPAOLO, M., FALORNI, A., DUNNEBACKE, R., PIERMATTEI, M., ALEJANDRO, R., and TSANG, W. G. Minerva Endocrinol., 1988, 13, (4), 287–292.
  • Xenotransplantation of microencapsulated porcine Islets of Langerhans into diabetic dogs. CALAFIORE, R., CALCINARO, F., PIETROPAOLO, M., BASTA, G., AVELLINI, L., and BRUNETTI, P. National Meeting of the American Federation for Clinical Research, Washington, D.C., USA, April 28-May 1, 1989. Clin. Res., 1989, 37, (2), 447A.
  • Reconstitution of the purified human IFN-gamma receptor IFN-gamma-r into liposomes. CALDERON, J., PINGEL, J., and SCHREIBER, R. D. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1101.
  • The use of liposomes of definite composition to modify keratinocytes membrane: the modulation of binding and endocytosis of concanavalin A. CALLAGHAN, T. M., ME TE ZEAU, P., GACHELIN, H., REDZINIAK, G., MILNER, Y., and GOLDBERG, M. E. Joint Meeting of the Society for Investigative Dermatology, European Society for Dermatologic Research, and Japanese Society for Investigative Dermatology, Washington, D.C., USA, April 26–30. 1989. Clin. Res., 1989, 37, (2), 746A.
  • Treatment of precocious puberty with an LH-RH agonist (D-TFLP6-LH-FtH delayed-release microcapsules). CANLORBE, P., CHAUSSAIN, J. L., LAHLOU, N., ROGER, M., TOUBLANC, J. E., and JOB, J. C. Bull. Acad. Natl. Med. (Paris), 1988, 172, (8), 1091–1098.
  • Combined effects exerted by amphotericin B and lucensomycin on cation permeability in a unilamellar vesicle system. CAPUOZZO, E., SALVI, S., SALERNO, C., and CRIFO, C., Biochimie, 1989, 71, (1), 57–61.
  • Characterization of the solubilized and reconstituted ATP-dependent vesicular glutamate uptake system. CARLSON, M. D., KISH, P. E., and UEDA, T. J. Biol. Chem., 1989, 264, (13), 7369–7376.
  • Physicochemical stabilization of lipid microspheres by coating with polysaccharide derivatives. CARLSSON, A., SATO, T., and SUNAMOTO, J. Bull. Chem. Soc. Jpn, 1989, 62, (3), 791–796.
  • Leakage of sulphobromophthalein from large simple bilayer phospholipid vesicles. CATALA, A., and ZANNETI, R. J. Microencapsulation, 1988, 5, (4), 319–324.
  • Studies on peroxidation of arachidonic acid in different liposomes below and above phase transition temperature. CERVATO, G., VIANI, P., MASSERINI, M., De IORIO, C., and CESTARO, B. Chem. Phys. Lipids, 1988, 49, (1-2), 135–139.
  • The acceleration of degradation-controlled drug delivery from polyester microspheres. Cm, Y., and PITT, C. G., J. Controlled Release, 1989, 8, (3), 259–265.
  • Characterization of temperature-dependent drug release from liposomes using electron spin resonance. CHAN, H. C., and MAGIN, R. L. J. Pharm. Sci., 1989, 78, (4), 311–313.
  • Artificial cells with ultrathin lipid-polymer or lipid-protein membranes. CHANG, T. M. Adv. Exp. Med. Biol., 1988, 238, 215–223.
  • Plasma/intestinal concentration patterns suggestive of enteroportal recirculation of amino acids: effects of oral administration of asparaginase, glutaminase, and tyrosinase immobilized by microencapsulation in artificial cells. CHANG, T. M. S., and LISTER, C. Biomater., Arti f Cells, Artif. Organs, 1989, 16, (5), 915–926.
  • Medical applications of artificial cells in transfusion, phenylketonuria, essential amino acid production, and liver support. CHANG, T. M. S. Ann. N. Y. Acad. Sci., 1988, 542 (Enzyme Eng. 9), 507–514.
  • Microencapsulation of tumor cells and assay for selecting anticancer drugs. CHEN, C. F., HWANG, J. M., JAo, S. W., LEU, F. J., and CHEN, K. Y. Proc. Natl. Sci. Counc. Repub. China (B), 1988, 12, (4), 252–261.
  • A study of the stability of liposomes from the total lipid fraction of E. coli by means of fluorescence spectroscopy and a radioisotope probe. CHERNIAVSKII, V. A., PASHKOVSICAIA, N. N., Amosov, F. T., and NIKOLAEV, B. P. Biofixika, 1988, 33, (6), 973–977.
  • Electrostimulated uptake of DNA by liposomes. CHERNOMORDIK, L. V., SoKoLov, A. V., and BUDKER, V. G. Biol. Membr., 1989, 6, (2), 212–217.
  • Characterization of liposome suspensions by flow cytometry. CHILDERS, N. K., MICHALEK, S. M., ELDRIDGE, J. H., DENYS, F. R., BERRY, A. K., and MCGHEE, J. R. J. Immunol. Methods, 1989, 119, (1), 135–143.
  • Quantification of right to left shunt through pulmonary arteriovenous malformations using 99Tcm albumin microspheres. CHILVERS, E. R., PETERS, A. M., GEORGE, P., HUGHES, J. M., and ALLISON, D. J. Clin. Radiol., 1988, 39, (6), 611–614.
  • Neutrophil-mediated transport of liposomes across the Maciin Darby canine kidney epithelial cell monolayer. Clio, M. J., SCIESZKA, J. F., CRAMER, C. T., THOMPSON, D. P., and VIDMAR, T. J. Pharm. Res., 1989, 6, (1), 78–84.
  • Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. CHOW, D. D., ESSIEN, H. E., PADKI, M. M., and HWANG, K. J. J. Pharmacol. Exp. Ther., 1989, 248, (2), 506–513.
  • Evaluation of the efficacy of a commercial microencapsulated diet for growth of juvenile American oysters. CHU, F. L. E., and GIBBONS, M. C. Annual Meeting of the National Shellfisheries Association, Los Angeles, California, USA, February 12–16. 1989. J. Shellfish Res., 1988, 7, (3), 572.
  • Effects of microgravity on liposome-reconstituted cardiac gap junction channeling activity. CLAASSEN, D. E., and SPOONER, B. S. Biochem. Biophys. Res. Commun., 1989, 161, (1), 358–362.
  • Pump current and Nal' /K* coupling ratio of Na-ATPase in reconstituted lipid vesicles.CLARICE, R. J., APELL, H. J., and LAUGER, P. Biochim. Biophys. Acta, 1989, 981, (2), 326–336.
  • Microencapsulated liposomes for the pulsed release of biologically active materials. COHEN, S., KIBAT, P. G., CHOW, M. B., and LANGER, R. S. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1989, 30, (1), 478–479.
  • Fluorescent latex microspheres as a retrograde tracer in the peripheral nervous system. COLIN, W., DONOFF, R. B., and FOOTE, W. E. Brain Res., 1989, 486, (2), 334–339.
  • Characterization of the porous structure of agglomerated microspheres by xenon-129 NMR spectroscopy. CON/4ER, W. C., WEIST, E. L., Pro, T., and FRAISSARD, if. Phys. Chem., 1989, 93, (10), 4138–4142.
  • Partition coefficients of tertiary amines between aqueous solutions and unilamellar liposomes. CONSTANTINESCU, A., IONESCU, M. S., MIHAILESCU, D., and MARGINEANU, D. G. Rev. Roum. Biochim., 1988, 25, (3), 269–274.
  • Selective removal of human T-cell populations from whole blood using monoclonal antibodies against CD2, CD3, CD4 and CD8 with goat-anti-mouse coated magnetic microspheres. CRAMER, D., DAVIES, D., and GALLAGHER, M. T. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1130.
  • Initial clinical trial of muramyl tripeptide derivative (MTP-PE) encapsulated in liposomes: An interim report. CREAVEN, P. J., BRENNER, D. E., COWENS, J. W., HUBEN, R., KARAKOUSIS, C., HAN, T., DADEY, B., ADREJCIO, K., and CUSHMAN, M. K. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p. A. R. Liss, New York, NY, USA, publ. 1989, pp. 297–304.
  • Functional reconstitution of photosynthetic cyclic electron transfer in liposomes. CRIELAARD, W., GABELLINI, N., HELLINGWERF, K. J., and KONINGS, W. N. Biochim. Biophys. Acta, 1989, 974, (2), 211–218.
  • Reconstitution of electrochromically active pigment-protein complexes from Rhodobacter sphaeroides into liposomes. CRIELAARD, W., HELLINGWERF, K. J., and KONINGS, W. N. Biochim. Biophys. Acta, 1989, 973, (2), 205–211.
  • Effects of free fatty acids and transition temperature on the stability of dry liposomes. CROWE, J. H., MCKERSIE, B. G., and CROWE, L. M. Biochim. Biophys. Acta, 1989, 979, (1), 7–10.
  • Liposomes as carrier systems for proteins factors affecting protein encapsulation. CRUZ, M. E., CORVO, M. L., JORGE, J. S., and LOPES, F. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988. 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 417–426.
  • Electrochemical aspects of the neutrophil response to surface-modified polystyrene microspheres. CUTTITTA, J. D., MARLOW, B. D., and DEBARI, V. A. Bioelectrochem. Bioenerg., 1989, 21, (1), 63–70.
  • Interaction of bovine skeletal muscle lactate dehydrogenase with liposomes. Comparison with the data for the heart enzyme. DABROWSKA, A., TERLECKI, G., and GUTOWICZ, J. Biochim. Biophys. Ada, 1989, 980, (3), 357–360.
  • Tumor cytotoxicity of liver macrophages and induced by liposome-associated immunomodulators. DAEMEN, T., HARDONK, M., KOUDSTAAL, J., OOSTERHUIS, W., DIJKSTRA, J., and SCHERPHOF, G. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 81–94.
  • Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes. DAEMEN, T., VENINGA, A., DIJKSTRA, J., and SCHERPHOF, G. J. Immunol., 1989, 142, (7), 2469–2474.
  • Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide. DAEMEN, T., VENINGA, A., ROERDINK, F. H., and SCHERPHOF, G. L. Biochim. Biophys. Ada, 1989, 991, (1), 145–151.
  • Modulation of doxorubicin resistance by valinomycin (NSC 122023) and liposomal valinomycin in Chinese hamster ovary cells. DAOUD, S. S., and JULIANO, R. L. Cancer Res., 1989, 49, (10), 2661–2667.
  • In vitro effect of liposome-incorporated valinomycin on growth, and macromolecular synthesis of normal and ras-transformed 3T3 cells. DAOUD, S. S., and JULIANO, R. L. Cancer Chemother. Pharmacol., 1989, 23, (3), 151–155.
  • Design and in vitro evaluation of polyvinyl chloride microcapsules containing sulphamethoxazole. DAS, S. K., and PALCLIOWDHURY, S. J. Microencapsul., 1989,6, (I), 53-58. High-power proton-decoupled deuterium nuclear magnetic resonance of liposomes. DATEMA, K. P., ADRIE-DE-JAGER, P., and HEMMINGA, M. A. J. Magn. Reson., 1989, 81, (3), 597-602. Microspheres as drug carriers. DAVIS, S. S., and Ilium, L. North. Biochent. Biophys., 1989, 9, 131–153.
  • Interaction of bovine skeletal muscle lactate dehydrogenase with liposomes. Comparison with the data for the heart enzyme. DCABROWSKA, A., TERLECKI, G., and GUTOWICZ, J. Biochim. Biophys. Acta, 1989, 980, (3), 357–360.
  • A garlic extract molecule structure and interactions with liposomes. DEBOUZY, J. C., NEUMANN, J. M., HEAVE, M., DAVELOOSE, D., VIRET, J., and APITZ-CASTRO, R. Tray. Sci. Chercheurs Serv. Sante-Armees, 1988, (9), 151–152.
  • PH-Dependent bilayer destabilization and fusion or phospholipidic large unilamellar vesicles induced by diphtheria toxin and its fragments a and b. DEFRISE-QUERTAIN, F., CABIAUX, V., VANDENBRANDEN, M., WATTIEZ, R., FALMAGNE, P., and RUYSSCGAERT, J. M. Biochemistry, 1989, 28, (8), 3406–3413.
  • New high-performance liquid chromatography-based methodology for monitoring the conformational transitions of self-associating hydrophobic peptides incorporated into liposomes. DEL-CARMEN-BANO, M., BRACO, L., and ABAD, C. J. Chromatogr., 1988, 458, 105–116.
  • New prospects offered by the administration of adenosine triphosphate (ATP) liposomes in experimental cerebral ischemia. DELATTRE, J., LAHAM, A., CLAPERON, N., CHAPAT, S., COUVREUR, P., PUISIEUX, F., and ROSSIGNOL, P. STP Pharma., 1989, 5, (2), 103–106.
  • A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. DELGADO, G., POTKUL, R. K., TREAT, J. A., LEWANDOWSKI, G. S., BARTER, J. F., FORST, D., and RAHMAN, A. Am. J. Obstet. Gynecol., 1989, 160, (4), 812–819.
  • Incorporation of cis-dichlorobiscyclopentylamine-platinum(H) into liposomes enhances its uptake by ADJ/PC6A tumor cells: comparative effects of the free and liposome-incorporate drug on the cyclic 3',5'-nucleotide phosphodiesterase activity. DELICONSTANTINOS, G. Anticancer Res., 1988, 8, (6), 1275–1278.
  • Magnetic carriers, a new tool for oncological therapy: Its role in radiology. DI-SALLE, F., CIRILLO, S., ROTONDO, A., ELEFANTE, R., and SMALTINO, F. Ross. Med. Sper., 1988, 35, (1-2), 7–32.
  • Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops and a novel depot formulation (nanoparticles). DIEPOLD, R., KREUTER, J., HIMBER, J., GURNY, R., LEE, V. H. L., ROBINSON, J. R., SAETTONE, M. F., and SCIINAUDIGEL, O. E. Grade's Arch. Clin. Exp. Ophthalmol., 1989, 227, (2), 188–193.
  • Amino resin microcapsules. II. Preparation and morphology. DIETRICH, K., BONATZ, E., GEISTLINGER, H., HERMA, H., NASTICE, R., PURZ, H. J., SCHLAWNE, M., and TEIGE, W. Acta Polym., 1989, 40, (5), 325–331.
  • Amino resin microcapsules. I. Literature and patent review. DIETRICH, K., HERMA, H., NASTKE, R., BONATZ, E., and TEIGE, W. Acta Polym., 1989, 40, (4), 243–251.
  • Microencapsulation of drugs with a mixture of polymers. I. Granulometric evaluation of microcapsules prepared by means of the emulsion method. DITTRICH, M., and MELICHAR, L. Cesk. Farm., 1989, 38, (1), 19–22.
  • Progress in development of synthetic erythrocytes made by encapsulation of hemoglobin. DioRDJEvicii, L., and IVANKOVICH, A. D. Adv. Exp. Med. Biol., 1988, 238, 171–197.
  • Chelating and antiradical effect of rutin during peroxidation of lipids from microsomes and liposomes. DOROZHKO, A. I., BRODSKII, A. V., and AFANAS'EV, I. B. Biokhimiia, 1988, 53, (10), 1660–1666.
  • Isolation of pure villous cytotrophoblast from term human placenta using immunomagnetic microspheres. DOUGLAS, G. C., and KING, B. F. J. Immunol. Methods, 1989, 119, (2), 259–268.
  • Sedimentation field flow fractionation of fused unilamellar vesicles: comparison with electron microscopy and gel filtration. DREYER, R., HAWROT, E., SARTORELLI, A. C., and CONSTANTINIDES, P. P. Anal. Biochem., 1988, 175, (2), 433–441.
  • Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies. DRUCKMANN, S., GABIZON, A., and BARENHOLZ, Y. Biochim. Biophys. Acta, 1989, 980, (3), 381–384.
  • In situ polymerization of a microencapsulating medium round living cells. DUPUY, B., GIN, H., BAQUEY, C., and DUCASSOU, D. J. Biomed. Mater. Res., 1988, 22, (11), 1061–1070.
  • Treatment of mycobacterium-avium complex infections by free and liposome-encapsulated tumor necrosis factor-alpha cachectin: Studies on peritoneal macrophages and the beige mouse model. DUZGUNES, N., PERUMAL, V. K., BRUNETTE, E. N., GANGADHARAM, P. R. J., and DEBS, R. J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 287–294.
  • The effect of liposomes' membrane composition on the binding of the photosensitizers Hpd and photofrin II. EHRENBERG, B., and GROSS, E. Photochem. Photobiol., 1988, 48, (4), 461-466. Liposomes: basic studies in clinical therapeutics. EKLUND, K. K., and KINNUNEN, P. K. Duodecim, 1989, 105, (1), 21–28.
  • Effect of particle size and film thickness on bioavailability and ulcerogenicity of encapsulated flufenamic acid. EL-MoNEm, A., FODA, M., and EL-SAID, Y. J. Microencapsulation, 1989,6, (2), 227–232.
  • Temperature sensitive liposomes: A controlled release system for the acceleration of cheese ripening. EL-SODA, M., JOHNSON, M., and OLSON, N. F. Milchwissenschaft, 1989, 44, (4), 213–214.
  • Biodegradable microspheres: vaccine delivery system for oral immunization. ELDRIDGE, J. H., GILLEY, R. M., STAAS, J. K., MOLDOVEANU, Z., MEULBROEK, J. A., and TICE, T. R. Curr. Top. Microbiol. Immunol., 1989, 146, 59–66.
  • Liposomal interferon-beta: sustained release treatment of simian varicella virus infection in monkeys. EPPSTEIN, D. A., VAN-DER-PAS, M. A., GLOFF, C. A., and SOME, K. F., J. Infect. Dis., 1989, 159, (4), 616–620.
  • Polymer drying. 1. Time-studies of desorption from liquid saturated poly(styrene-co-divinylbenzene) microparticles. ERREDE, L. A., KUEKER, M. J., TIERS, G. V. D., and VAN BOGART, J. W. C. J. Polym. Sc., Part A: Polym. Chem., 1988, 26, (12), 3375–3389.
  • Reversible oxygen-binding to imidazolyl-group-bearing 5,10,15,20-tetrakis(alpha, alpha, alpha, alpha-o-pivalamidophenyl) porphyrinatoiron(II) in its micellar or liposome solution. ESHIMA, K., YUASA, M., NISHIDE, H., and TSUCHIDA, E. Nippon Kagaku Kaishi, 1988, (11), 1846–1851.
  • Liposome-encapsulated hemoglobin: a synthetic red cell. FARMER, M. C., JOHNSON, S. A., BEISSINGER, R. L., GOSSAGE, J. L., LYNN, A. B., and CARTER, K. A. Adv. Exp. Med. Biol., 1988, 238, 161–170.
  • Comparison of solute partitioning and efflux in liposomes formed by a conventional and an aerosolized method. FARR, S. J., KELLAWAY, I. W., and CARMAN-MEAKIN, B. Int. J. Pharm., 1989, 51, (I), 39–46.
  • Microspheres in plasma show no aggregation. FARRAR, S., and SCHEEL, K. W. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March, 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1306.
  • Bone marrow uptake of liposome-entrapped spin label after liver blockade with empty liposomes. FEDERICO, M., IANNONE, A., CHAN, H. C., and MAGIN, R. L. Magn. Reson. Med., 1989, 10, (3), 418–425.
  • Combined 113Xe/99mTC human serum albumin microspheres lung scintigraphy in children with recurrent and chronic bronchitis. FEIN, R., THAL, W., OTTO, H. J., and GUNICEL, H. Z. Erkr. Atmungsorgane., 1988, 171, (2), 135–142.
  • Encapsulated water-soluble dyes for plain paper transfer imaging. FELDMAN, L. Res. Disci., 1989, 298, 146.
  • One step lamination and development of receiver sheet for imaging systems employing photohardenable microcapsules. FELDMAN, L. Res. Disci., 1989, 298, 135–136.
  • Microcolumn imaging-a simulation of the microcapsule imaging system. FELDMAN, L., CAGE, M. R., Stu, D. J., and LIANG, R. C. Polym. Mater. Sci. Eng., 1989, 60, 113–116.
  • The use of liposomes as drug carriers in the immunotherapy of cancer. FIDLER, I. J. Horiz. Biochem. Biophys., 1989, 9, 213–248.
  • Potent in situ activation of murine lung macrophages and therapy of melanoma metastases by systemic administration of liposomes containing muramyltripeptide phosphatidylethanolamine and interferon gamma. FIDLER, I. J., FAN, D., and ICHINOSE, Y. Invasion Metastasis, 1989, 9, (2), 75–78.
  • The reaction of bisulfite with liposomal membranes. FINCH, L., and SOUTHERLAND, W. M. Biosci. Rep., 1988, 8, (5), 443–448.
  • Phospholipid bilayers enhance the stability of leukotriene A4 and epoxytetraenes: stabilization of eicosanoids by liposomes. FIORE, S., and SERHAN, C. N. Biochem. Biophys. Res. Commun., 1989, 159, (2), 477–481.
  • Laser transfer printing using microencapsulated dyes. FISCHER, B., MADER, G., MEIXNER, H., and KLEINSCHMIDT, P. Siemens Forsch. Entwicklungsber, 1988, 17, (6), 291–297.
  • Effect of particle size and film thickness on bioavailability and ulcerogenicity of encapsulated flufenamic acid. FODA, A.-EL-M., and EL-SAID, Y. J. Microencapsulation, 1989, 6, (2), 227–232.
  • The influence of conditions in which erythrocyte ghosts are obtained on their radiosensitivity. FOMENKO, B. S., and DLIMBETOVA, G. K. Radiobiologiya, 1988, 28, (6), 783–786.
  • Establishment of an experimental model of a Staphylococcus aureus abscess in mice by use of dextran and gelatin microcarriers. FORD, C. W., HAMEL, J. C., STAPERT, D., and YANCEY, R. J. J. Med. Microbiol., 1989, 28, (4), 259–266.
  • Gentamicin alters membrane structure as shown by freeze-fracture of liposomes. FORGE, A., ZApc, G., DAVIES, S., WEINER, N., and SCHACHT, J. Hear. Res., 37, (2), 129–139.
  • Development of dehydroemetine nanoparticles for the treatment of visceral leislunaniasis. FOUARGE, M., DEWULF, M., COUVREUR, P., ROLAND, M., and VRANCKX, H. J. Microencapsulation 1989, 6, (1), 29–34.
  • T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnefic beads. FRAME, J. N., COLLINS, N. H., CARTAGENA, T., WALDMANN, H., O'REILLY, R. J., DUPONT, B., and KERNAN, N. A. Transplantation, 1989, 47, (6), 984–988.
  • Biologic activity of liposome encapsulated interferon alpha in human bladder tumor cells. FRANGOS, D. M., KILLION, J. J., FAN, D., VON-ESCHENBACH, A. C., and FIDLER, I. J. AUA (American Urological Association) 84th Annual Meeting, Dallas, Texas, USA, May 7–11. 1989. J. Urol., 1989, 141, (4, Part 2), 292A.
  • Use of liposomes for protective immunisation against Crotalus durissus (tropical rattlesnake) venom. FREITAS, T. V., TAVARES, A. P., THEAKSTON, R. D., LAING, G., and NEW, R. R. Toxicon, 1989, 27, (3), 341–347.
  • Interactions of colicin A domains with phospholipid monolayers and liposomes: relevance to the mechanism of action. FRENETTE, M., KNIBIEHLER, M., BATY, D., GELI, V., PATTUS, F., VERGER, R., and LAZDUNSKI, C. Biochemistry, 1989, 28, (6), 2509–2514.
  • Microencapsulated parathyroid cells as a bioartificial parathyroid. In vivo studies. Fu, X. W., and SUN, A. M. Transplantation, 1989, 47, (3), 432–435.
  • Nuclear magnetic resonance spectroscopic studies of the interaction of methyl methacrylate and ethylene dimethacrylate with phosphatidylcholine liposomes as a model for biomembranes. FupsAwA, S., KADOMA, Y., and KOMODA, Y. Biomaterials, 1989, 10, (1), 51–55.
  • NMR spectroscopic studies of interaction of bis-GMA analogues with phosphatidylcholine liposomes as a model for biomembranes. FupsAwA, S., KADOMA, Y., and KOMODA, Y. Biomaterials, 1989, 10, (4), 269–272.
  • Blood modeling using polystyrene microspheres. FUKADA, E., SEAMAN, G. V. F., LIEPSCH, D., LEE, M., and FRIIS-BAASTED, L. Biorheology, 1989, 26, (2), 401–414.
  • Incorporation of toxin pores into liposomes. FUSSLE, R., TRANUM-JENSEN, J., SZIEGOLEIT, A., and BHAKDI, S. Methods Enzymol., 1988, 165, 285–293.
  • Reconstitution of cyclic electron transport and photophosphorylation by incorporation of the reaction center, cytochrome bc1 complex and ATP synthase from Rhodobacter capsulatus into ubiquinone-10/phospholipid vesicles. GABELLINI, N., GAO, Z., OESTERHELT, D., VENTUROLI, G., and MELANDRI, B. A. Biochim. Biophys. Acta, 1989, 974, (2), 202–210.
  • Liposome-based immunoassays for detection of small and large molecules. GABER, B. P., LIGLER, F. S., and BREDEHORST, R. Adv. Exp. Med. Biol., 1988, 238, 209–214.
  • Liposomes as a drug delivery system in cancer chemotherapy. GABIZON, A. Horiz. Biochem. Biophys., 1989, 9, 185–211.
  • Liposome-associated doxorubicin preclinical pharmacology and exploratory clinical phase. GABIZON, A., SULKES, A., PERETZ, T., DRUCKMANN, S., GOREN, D., AMSELEM, S., and BARENHOLZ, Y. G. Lopez-Bernstein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 391–402.
  • Self-digestion and vesiculation of bovine erythrocyte ghosts. GACZYNSKA, M. Cytobios, 1988, 56, (226-227), 149–156.
  • Induction of colony-stimulating activity in mice by injection of liposomes containing lipophilic muramyl peptide derivatives. GALELLI, A., CHARLOT, B., PHILLIPS, N. C., and CHEDID, L. Cancer Res., 1989, 49, (4), 810–815.
  • Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat. GALLO, J. M., GUPTA, P. K., HUNG, C. T., and PERRIER, D. G. J. Pharm. Sci., 1989, 78, (3), 190–194.
  • Receptor-mediated magnetic carriers: basis for targeting. GALLO, J. M., and HASSAN, E. E. Phartn. Res., 1988, 5, (5), 300–304.
  • Comparative activities of free and Liposome encapsulated amikacin against mycobacterium-avium complex (MAC). GANGADHARAM, P. R. J., PERUMAL, V. K., KESAVALU, L., DEBS, R. J., GOLDSTEIN, J., and DUZGUNES, N. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988. 480p, A. R. Liss, New York, NY, USA, 1989, pp. 177–190.
  • Sol-gel microsphere pelletization of ceramic nuclear fuels. GANGULY, C. Mater. Sci. Forum, 1988, 34–36 (Int. Ceram. Conf., AUSTCERAM 88, Pt. 2), 845–849.
  • Structure of hollow polystyrene microspheres: an SEM study. GANGULY, S., Rao, K. V., and MOHAN, V. K. J. Microencapsulation, 1989, 6, (2), 193–198.
  • Delivery systems for hydrophobic drugs. GARBO, G. M., and MORGAN, A. R. J. Photochem. Photobiol. B., 1988, 1, (4), 494–495.
  • Action of gastric juice on microencapsulated invertase. GARCIA, I., AISINA, R. B., ANCHETA, 0., and PASCUAL, C. Enzyme Microb. Technol., 1989, 11, (4), 247–251.
  • Liposomes of enviroxime and phosphatidylcholine: definition of the drug-phospholipid interactions. GARCON, N. M., Six, H. R., FRAZER, J., HAZLEWOOD, C., GILBERT, B. E., and KNIGHT, V. Antiviral Res., 1989, 11, (2), 89–98.
  • Incorporation of doxorubicine in nanoparticles obtained by polymerization from nonaqueous micromulsion. GASCO, M. R., MOREL, S., and MANZONI, R. Farmaco (Prat.), 1988, 43, (12), 373–380.
  • Continuous spectrofluorometric measurements of the dispersion state and the uptake of pyrene dodecanoic acid by liposomes and cells. GATT, S., and FIBACH, E. NATO AS Ser., Ser. A, 1988, 150 (Lipid Storage Disord.), 533–538.
  • Trypanocidal activity of isobutyl cyanoacrylate nanoparticles in Trypanosoma brucei brucei-infected mice. GAYRAL, P., BORIES, C., LOISEAU, P., and COUVREUR, P. Bull. Soc. Fr. Parasitol., 1988, 6, (1), 21–26.
  • The interaction of bone Gla protein (osteocalcin) with phospholipid vesicles. GENDREAu, M. A., KRISHNASWAMY, S., and MANN, K. G. J. Biol. Chem., 1989, 264, (12), 6972–6978.
  • Identification of phospholipid-dependent calcium-binding proteins as constituents of matrix vesicles. GENGE, B. R., Wu, L. N., and WuTHIER, R. E. J. Biol. Chem., 1989, 264, (18), 10917–10921.
  • A combination of hypothalamic phospholipid liposomes with trazodone for treatment of depression. An open controlled study. GIANNELLI, A., RABBONI, M., ZARATTINI, F., MALGERI, C., and MAGNOLFI, G. Acta Psychiatr. Scand., 1989, 79, (1), 52–58.
  • Inhibition of interferon gamma-induced macrophage microbicidal activity against Leishmania major by Liposomes: inhibition is dependent upon composition of phospholipid headgroups and fatty acids. GILBREATH, M. J FOGLER, W. E., SWARTZ, G. M. Jr, ALVING, C. R., and MELTZER, M. S. Int. J. Immunopharmacol., 1989, 11, (2), 103–110.
  • Polycations and biological membranes in MCN misinterpretation and perspectives. GINEVRI, F., CANDIANO, G., GHIGGERI, G. M., OLEGGINI, R., BERTELLI, R., PERFUMO, F., QUEIROLO, C., and GUSMANO, R. Abstracts of the Italian Society of Nephrology, Messina-Giardini Naxos, Italy, June 8–11. 1988. Kidney Int., 1989, 35, (2), 760.
  • The impact of liposome encapsulation of gentamicin on the treatment of extracellular gram-negative bacterial infections. GINSBERG, R. S., MITILENES, G. M., LENK, R. P., JEDRUSIAK, J.
  • A., SAVAGE, K., and SWENSON, C. E. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 205–214.
  • The interaction of coenzyme Q and vitamin E with multibilayer liposomes. GOMEZ-FERNANDEZ, J. C., ARANDA, F. J., VILLALAIN, J., and ORTIZ, A. Adv. Exp. Med. Biol., 1988, 238, 127-139. Surfactant-induced liposome fusion: molecular mechanisms and biotechnological applications. GoNi, F. M., and Atom°, A. Adv. Exp. Med. Biol., 1988, 238, 81–103.
  • A grating velocimeter for use with fluorescent microspheres. GOODMAN, A. H. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19-23, 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1387.
  • Experimental therapy of Lesch-Nyhan disease with microencapsulated xanthine oxidase. GOODYER, P., PALMOUR, R., READE, T., HESHKA, T., ROSENBLATT, B., and CHANG, T. Joint Meeting of the American Pediatric Society and the Society for Pediatric Research, Washington, D.C., USA, May 1–4. 1989. Pediatr. Res., 1989, 25, (4, part 2), 141A.
  • Animal cell culture engineering using alginate polycation microcapsules of controlled membrane molecular weight cut-off. GOOSEN, M. F. A., KING, G. A., MCKNIGHT, C. A., and MARCOTTE, N. J. Membr. Sci., 1989, 41, 323–343.
  • Evaluation of the sustained release properties of Eudragit RS, RL and S (acrylic resins) microcapsules containing ketoprofen in beagle dogs. GOTO, S., KAWATA, M., NAKAMURA, M., NAGATSUMA, Y., FUJINAGA, K., and AOYAMA, T. J. Microencapsulation, 1988, 5, (4), 343-360. Detection of a novel binding site for butanol in DPPC/GM1 liposomes by 2H NMR spectroscopy. GRAHAM-BRITTAIN, C., HITZEMANN, R. J., and KREISHMAN, G. P. Prog. Clin. Biol. Res., 1989, 292, 23–31.
  • Dilauroylphosphatidylcholine liposome effects on the acrosome reaction and in vitro penetration of zona-free hamster eggs by bull sperm: II. A fertility assay for frozen-thawed semen. GRAHAM, J. K., and FOOTE, R. H. Gamete Res., 1987, 16, (2), 147–158.
  • Dilauroylphosphatidylcholine liposome effects on the acrosome reaction and in vitro penetration of zona-free hamster eggs by bull sperm: I. A fertility assay for fresh semen. GRAHAM, J. K., and FOOTE, R. H. Gamete Res., 1987, 16, (2), 133–145.
  • Synergistic effects in praseodymium(3 *) transport mediated by ionophores across phosphatidylcholine vesicles. GRANDJEAN, J., and LASLO, P. Biochimie, 1989, 71, (1), 183–186.
  • Treatment of pseudomonas corneal ulcer with tobramycin liposomes. GREENBERG, D., FRUCHT-FERY, J., AMC., K., ZIEGLER, F., SCHNEIDERMAN, T., BROWN, S., DOUGLAS, H., and WEINREB, R. N. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 195.
  • Liposomes as a drug delivery system: optimization studies. GREGORIADIS, G. Adv. Exp. Med. Biol., 1988, 238, 151–159.
  • Liposomes as carriers of drugs. Observations on vesicle fate after injection and its control. GREGORIADIS, G. Subcell. Biochem., 1989, 14, 363–378.
  • The immunoadjuvant action of liposomes. GREGORIADIS, G., DAVIS, D., GARCON, N., TAN, L., WEISSIG, V., and X1A0, Q. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 35–36.
  • Immunoadjuvant action of liposomes: comparison with other adjuvants. GREGORIADIS, G., and FANAGIOTIDI, C. Immunol. Lett., 1989, 20, (3), 237–240.
  • A novel method for the covalent coupling of sugars to liposomes. GREGORIADIS, G., WEISSIG, V., TAN, L., and Xmo, Q. 27th Annual Meeting of the Biochemical Society, Nottingham, England, UK. Biochem. Soc. Trans, 1989, 17, (1), 128–129.
  • Hydrolysis of phosphatidylcholine in aqueous liposome dispersions. GRIT, M., DE-SMIDT, J. H., STumpo, A., and CROMMELIN, D. J. A. Int. J. Pharm., 1989, 50, (1), 1–6.
  • A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study. GRUBB, G. S., WELCH, J. D., COLE, L., GOLDSMITH, A., and RIVERA, R. Fertil. Steril., 1989, 51, (5), 803–810.
  • Synthesis of fluorocarbon phospholipids and the formation of their liposomes. Gu, J., Luo, S., KONG, H., Hut, Y. Huaxue Xuebao, 1988, 46, (9), 913–918.
  • Studies on the microencapsulation of dextropropoxyphene hydrochloride. Part 2. The in vivo urinary excretion in matt. GULER, E., Suumu, M., and YAZAN, Y. Drug Dev. Ind. Pharm., 1989, 15, (2), 295–301.
  • Studies on the microencapsulation of dextropropoxyphene hydrochloride. Part 1. Preparation by coacervation and the in vitro evaluation. GULER, E., SumNu, M., YAZAN, Y., and ONER, L. Drug. Dev. Ind. Pharm., 1989, 15, (2), 283–293.
  • Peculiarities of changes in the potassium-p-nitrophenylphosphatase of erythrocyte ghosts under the action of ouabain. GULIDOVA, G. P., and CHEKRYGINA, 0. N. Ukr. Biokhim. Zh., 1989, 61, (1), 82–85.
  • Changes in gonadotropin estradiol and ovarian LH-HCG receptor concentrations over time after injection of microencapsulated histrelin, a potent GnItH agonist. GUNNET, J. W., DEMAREST, K. T., HAHN, D. W., ERICSON, E., and McGuluE, J. L. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (3), A282.
  • Magnetite as a tracer for the estimation of biodistribution of microspheres: a critical consideration. GUPTA, P. K. Int. J. Pharm., 1989, 52, (1), 87–89.
  • Factorial design based optimization of the formulation of albumin microspheres containing adriamycin. GUPTA, P. K., HUNG, C. T., and LAM, F. C. J. Microencapsulation, 1989, 6, (2), 147–160.
  • Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats. GUPTA, P. K., HUNG, C. T., and RAO, N. S. J. Pharm. Sci., 1989, 78, (4), 290–294.
  • Albumin microspheres. IV. Effect of protein concentration and stabilization time on the release rate of adriamycin. GUPTA, P. K., LAM, F. C., and HUNG, C. T. Int. J. Pharm., 1989, 51, (3), 253–258.
  • Quantitative assessment of retinal hemodynamics by targeted dye delivery: An in vivo feasibility study. GURAN, T., Mom, M. T., SHAHIDI, M., and ZEIMER, R. C. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 368.
  • Drug targeting in Leishmania donovani infections using tuftsin-bearing liposomes as drug vehicles. GURU, P. Y., AGRAWAL, A. K., SINGHA, U. K., SINGHAL, A., and GUPTA, C. M. FEBS Lett., 1989, 245, (1-2), 204–208.
  • Effect of human plasma on the stability of large multilamellar liposomes with digitoxin. GUZMAN, M., SELLES, E., and ABERTURAS, M. C. Drug. Dev. Ind. Pharm., 1989, 15, (3), 387–399.
  • Phase I development of CGP- 1919835A lipid MTP-PE encapsulated in liposomes. HANAGAN, J. R., TRUNET, P., LESHER, D., ANDREJCIO, K., and FROST, H. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 305–316.
  • Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble _ polyamide and a process for preparing these compositions. US Patent 4,830,857; May 16, 1989. HANDJANI, R. M., RIBIER, A., VANLERBERGHE, G., ZABOTTO, A., and GRIAT, J. Off. Gaz. US Pat. Trademark Off. Pat., 1989, 1102, (3), 1845–1846.
  • Interaction of hexahydro(1)benzopyranobenzodiazepine derivatives with liposomes as studies by absorption spectroscopy and fluorescence probe technique. HANSCHMANN, H., GELLER, K., STUTTER, E., and LOEBER, G. Stud. Biophys., 1989, 128, (1), 51–61.
  • Effect of ethanol on dimyristoylphosphatidylcholine large unilamellar vesicles investigated by quasi-elastic light scattering and vibrational spectroscopy. HANTZ, E., CAO, A., and TAILLANDIER, E. Chem. Phys. Lipids, 1988, 49, (3), 143–151.
  • Manufacture of poly(alkyl cyanoacrylate) nanoparticles with pilocarpine and timolol by micelle polymerization: factors influencing particle formation. HARMIA-PULKKINNEN, T., Tuoml, A., and KRISTOFFERSSON, E. J. Microencapsulation, 1989, 6, (1), 87–93.
  • Characterization of a lipophilic prodrug of 5-fluorouracil with a cholesterol promoiety and its application to liposomes. HASHIDA, M., SATO, K., TAKAKURA, Y., and Sszssi, H. Chem. Pharm. Bull., 1988, 36, (8), 3186–3189.
  • Effect of operating conditions on characteristics of microcapsules by in situ polymerization. HATATE, Y., HAMADA, H., NAGATA, H., SAKAKI, K., KASAMATSU, K., hum, A., and NAKASIO, F. Kenkyu Hokoku-Asahi Garasu Kogyo Gijutsu Shoreikai, 1988, 52, 247–253.
  • Lens vitamin E intake by instillation of vitamin E-containing liposome. HAI-rota, H. II., MAjims, Y., ISHIGURO, I., NAGAMURA, Y., and TORII, H. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 94.
  • Lens vitamin E intake after topical instillation of vitamin E-containing liposome. HATTORI, H., Msjims, Y., NAGAMURA, Y., and Istimuso, I. Atarashii Ganka, 1988, 5, (12), 1752-1756. Stabilization of small, unilamellar phospholipid vesicles by sucrose during freezing and dehydration. HAUSER, H., and STRAUSS, G. Adv. Exp. Med. Biol., 1988, 238, 71–80.
  • Flavins in liposomes-anomalous photochemical effects at high pigment concentrations. HEELIS, P. F., PHILLIPS, G. 0., LENCI, F., and COLOMBETTI, G. Photochem. Photobiol., 1989, 49, (3), 361–362.
  • Introduction of macromolecules into primary cultured neuronal cells by fusion with erythrocyte ghosts. HIKAWA, N., HORIE, H., KAWAKAMI, T., OKUDA, K., and TAICENAICA, T. Brain Res., 1989, 481, (1), 162–164.
  • Antigen-presenting liposomes are effective in treatment of recurrent herpes simplex virus genitalis in guinea pigs. Ho, R. J., BURICE, R. L., and MERIGAN, T. C. J. Virol., 1989, 63, (7), 2951–2958.
  • Inhibition of adhesion of viridans streptococci to flbronectin-coated hydroxyapatite beads by lipoteichoic acid. H000, S. D., and MANNING, J. E. J. Appl. Bacteriol., 1988, 65, (6), 483–489.
  • pH-Sensitive and target sensitive immunoliposomes for drug targeting. HOLMBERG, E. G., and HUANG, L. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 25–34.
  • Proteolysis of N-ethylmaleimide-modifled aldolase loaded into erythrocyte ghosts: prevention by inhibitors of calpain. HOPGOOD, M. F., KNOWLES, S. E., and BALLARD, F. J. Biochem. J., 1989, 259, (1), 237–242.
  • A study on the thermostability of microencapsulated glucose oxidase. HostuNo, K., MURAMATSU, N., and KONDO, T. J. Microencapsulation, 1989, 6, (2), 205–211.
  • Effect of attachment of anticandidal antibody to the surfaces of liposomes encapsulating amphotericin B in the treatment of murine candidiasis. HOSPENTHAL, D. R., ROGERS, A. L., and BENEKE, E. S. Antimicrob. Agents Chemother., 1989, 33, (1), 16–18.
  • Surface charged liposomes as drug carriers and in vivo tests of mice infected with toxoplasma. Hou, X. P., TAO, F., Y1, Y. Y., and WANG, W. L. Yaoxue Xuebao, 1989, 24, (1), 53-57. Preparation of microspheres of water-soluble pharmaceuticals. HUANG, H. P., and GHEBRE- SELLASSIE, I. J. Microencapsulation, 1989, 6, (2), 219–225.
  • Antihypertensive effect of a nanocapsular form of the calcium entry blocker darodipine. HUBERT, B., MAINCENT, P., GUERRET, M., and ATKINSON, J. Meeting of the British Pharmacological Society, London, England, UK, December 19–21. 1988. Br. J. Pharmacol., 1989, 96, (suppl.), 184 p.
  • The integrity of proteoliposomes targeted to a model biosurface. HUTCHINSON, F. J., FRANCIS, S. E., and JONES, M. N. Biochem. Soc. Trans., 1989, 17, (3), 558–559.
  • Biological activity of several PGE1 esters and their application to lipid microsphere (LM) preparations. IGARASHI, R., NAKAGAWA, M., and MIZUSHIMA, Y. Ensho, 1988, 8, (3), 243–246.
  • Release and degradation characteristics and antitumor effect of adriamycin-containing poly-L-lactic acid microspheres. IKE, 0., WATANABE, S., NAICAMURA, T., WADA, R., HYON, S. H., HITOMI, S., IKADA, Y., and SHImtzu, Y. C. de Putter etal. (Eds). Advances in Biomaterials, Vol. 8. Implant Materials in Biofunction; Seventh European Conference on Biomaterials, Amsterdam, Netherlands, September 8–11. 1987, 508 p, Elsevier, Amsterdam, Netherlands, publ. 1988, pp. 257–262.
  • Effect of liposome-encapsulated pentacin on plutonium-239 excretion. ILIN, L. A., IVANNIKOV, A. T., ALTUKHOVA, G. A., PARFENOVA, I. M., and CHELYSHEVA, T. V. Radiobiologiia, 1989,29, (2), 197–201.
  • Conversion of ammonia to glutamate by L-glutamic dehydrogenase, alcohol dehydrogenase and NAD+ immobilized within lipid-polyamide polyethyleneimine microcapsules. ILAN, E., and CHANG, T. M. S. Adv. Exp. Med. Biol., 1987, 223 (Uremic Toxins), 189–192.
  • Production and metabolism of cytotoxic phospholipids generated during incubation of liposomes with oxyhemoglobin. INouE, K., ITABE, H., and KUDO, I. Basic Life Sci., 1988, 49, 291–300.
  • Preparation of EGF labeled liposomes and their uptake by hepatocytes. Ismi, Y., ARAMAKI, Y., HARA, T., TSUCHIYA, S., and FUWA, T. Biochem. Biophys. Res. Commun., 1989, 160, (2), 732–736.
  • Immobilization of enzyme by microencapsulation and application of the encapsulated enzyme in the catalysis. Iso, M., SHIRAHASE, T., HANAMURA, S., URUSHIYAMA, S., and Omt, S. J. Microencapsulation, 1989, 6, (2), 165–176.
  • The influence of lipid-detergent ratio on the process of solubilization of phosphatidylcholine liposomes. IVANOV, N. N., YULINA, V. V., OVORYANTSEV, S. N., PERTSOV, A. V., RUUGE, E. K., and TORCHILIN, V. P. Biol. Membr., 1988, 5, (10), 1067–1071.
  • Microencapsulation of islets in novel polyion-complex membranes and its evaluation as a bioartificial pancreas. IWATA, H., MATSUDA, T., AMEMIYA, H., TAKANO, H., and AKUTSU, T. C. De Putter et al. (Eds). Advances in Biomaterials, Vol. 8. Implant Materials in Biofunction; Seventh European Conference on Biomaterials, Amsterdam, Netherlands, September 8–11. 1987, 508 p, Elsevier, Amsterdam, Netherlands, publ. 1988, pp. 497–502.
  • Microencapsulation of Langerhans islets in agarose microbeads and their application for a bioartificial pancreas. IWATA, H., AMEMIYA, H., MATSUDA, T., TAKANO, H., and AKUTSU, T. J. Bioact. Compat. Polym., 1988, 3, (4), 356–369.
  • Conformational change of band 3 protein induced by diethyl pyrocarbonate modification in human erythrocyte ghosts. IZUHARA, K., OKUBO, K., and HAMASAKI, N. Biochemistry, 1989,28, (11), 4725–4728.
  • Effects of phosphatidylcholine on the topical bioavailability of corticosteriods assessed by the human skin blanching assay. JAcous, M., MARTIN, G. P., and MARRIOTT, C. J. Pharm. Pharmacol., 1988, 40, (12), 829–833.
  • The nature of the hydrophobic binding of small peptides at the bilayer interface: implications for the insertion of transbilayer helices. JAcoss, R. E., and WHITE, S. H. Biochemistry, 1989, 28, (8), 3421–3437.
  • Neo-pathway formation of dissociated neural grafts demonstrated by immunocytochemistry, fluorescent microspheres, and retrograde transport. JAEGER, C. B., and WOLF, A. K. Brain Res., 1989, 487, (2), 225–237.
  • Development of biodegradable microcapsules for controlled drug release into the brain. JALSENJAK, V., STOLNIK, S., and JALSENJAK, I. Acta Pharm. Jugosl., 1988, 38, (4), 297–305.
  • Locating spin traps in heterogeneous media by carbon-13 NMR spectroscopy. Investigations in SDS micelles, DMPC vesicles, and rat liver microsomes. JANZEN, E. G., HAIRE, D. L., COULTER, G. A., STRONKS, H. J., KRYGSMAN, P. H., TOWNER, R. A., and HILBORN, J. W. J. Org. Chem., 1989, 54, (12), 2915–2920.
  • Dose titration optimization of tumor derived soluble antigen and liposome associated soluble antigen pre-immunization of Copenhagen rats against Dunning prostate adenocarcinoma growth. JARowsrixo, M. V., CURLEY, R. M., ENGLISH, H., and ROHNER, T. J. JR. AUA (American Urological Association) 84th Annual Meeting, Dallas, Texas, USA, May 7–11. 1989. J. Urol., 1989, 141, (4, part 2), 179A.
  • Effect of free and liposome associated donor derived soluble antigen on cardiac allograft survival in the rat. JAsowsxxo, M. V., CURLEY, R. M., Qt, J., and ROHNER, T. J. JR. AUA (American Urological Association) 84th Annual Meeting, Dallas, Texas, USA, May 7–11. 1989. J. Urol., 1989, 141, (4, part 2), 344A.
  • Microencapsulation of activable radiotherapeutic agents. JAY, M., KHARE, S. S., MUMPER, R. J., and RYO, U. Prog. Clin, Biol. Res., 1989, 292 (Biol. Synth. Membr.), 293–300.
  • Liposomes as drug carriers in the therapy of infectious diseases. JuLIANo, R. L., Horiz. Biochem. Biophys., 1989, 9, 249–279.
  • Study of the effects of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans, and erythrocytes by using small unilamellar vesicles prepared from saturated phospholipids. JULLIEN, S., CONTREPOIS, A., SLIGH, J. E., DOMART, Y., YENI, P., BRAJTBURG, J., MEDOFF, G., and BOLARD, J. Antimicrob. Agents Chemother., 1989,33, (3), 345–349.
  • Nucleic acid sandwich hybridization: enhanced reaction rate with magnetic microparticles as carriers. JUNGELL NORTAMO, A., SYVANEN3 A. C., LUOMA, P., and SODERLUND, H. Mo/. Cell. Probes, 1988, 2, (4), 281–288.
  • Vaccination against murine cutaneous leishmaniasis by using Leishmania major antigen/liposomes. Optimization and assessment of the requirement for intravenous immunization. KAHL, L. P., SCOTT, C. A., LELCHUK, R., GREGORIADIS, G., and LIEW, F. V. J. Immunol., 1989, 142, (12), 4441–4449.
  • Reconstitution of the mitochondrial non-selective sodium/hydrogen ion (potassium/hydrogen ion) antiporter into proteoliposomes. KAKAR, S. S., MARDI, F., Li, X. Q., and GARLID, K. D. J. Biol. Chem., 1989, 264, (10), 5846–5851.
  • Optimization of a method of microencapsulation by phase separation. Role of the hydroxypropyl methyl cellulose as a nucleating agent. KALTSATOS, V., ROLLET, M., and PEREZ, J. STP Pharma, 1989, 5, (2), 96–102.
  • Interaction of microspheres with blood constituents. III. Macrophage phagocytosis of various types of polymeric drug carriers. KANICE, M., GEISSLER, R. G., POWELL, D., KAPLAN, A., DELucA, P. P. J. Parenter. Sci. Technol., 1988, 42, (5), 157–165.
  • Liposomes: fusion and redistribution of the suspension components at temperatures 0° to minus 150°C. KAPANIN, P. V., MIKHALEV, 0. I., and TROFIMOV, V. I. Cryo. Lett., 1989, 10, (1), 59–68.
  • Dynamic fluorescence polarization studies on lipid mobilities in phospholipid vesicles in the presence of calcium mediators. KAUL, P., and KOTHEKAR, V. J. Biosci. (Bangalore), 1988, 13, (4), 359–366.
  • The formation of the M-type intermediate in the photocycle of 13-cis-bacteriorhodopsin II. Bacteriorhodopsin-containing liposomes and purple membranes. KAULEN, A. D., and ZORINA, V. V., Biol. Membr., 1988, 5, 11, 1135–1144.
  • Complex coacervation between colloidal silica and polyacrylamide. KAWASE, K., SAKAMI, H., and HAYAKAWA, K. Kobunshi Ronbunshu, 1989, 46, (3), 161–168.
  • Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. KAWASHIMA, Y., NIWA, T., HANDA, T., TAKEUCHI, H., IwAmoTo, T., and ProH, K. J. Pharm. Sci., 1989, 78, (I), 68–72.
  • Preparation of prolonged-release spherical micro-matrix of ibuprofen with acrylic polymer by the emulsion-solvent diffusion method for improving bioavailability. KAWASHIMA, Y., NIWA, T., HANDA, T., TAKEUCHI, H., IwAmoTo, T., and ITO, V. Chem. Pharm. Bull., 1989,37, (2), 425–429.
  • Possible approaches to creating phospholipid preparations-acceptors of membrane cholesterol. KHALILOV, E. M., TORKHOVSKAIA, T. I., FORTINSKAIA, E. S., KALIMAN, A. M., and KOCHETOVA, M. M. Biull. Eksp. Biol. Med., 1989, 107, (4), 451–453.
  • Employment of magnet-susceptible microparticles for the targeting of drugs. KEIARKEVICH, D. A., ALYAUTDIN, R. N., and FILIPPOV, V. I. J. Pharm. Pharmacol., 1989, 41, (4), 286–288.
  • Toxicity and antitumor activity of cis-bis-carboxylato(trans-R, R-1,2-diaminocyclohexane) platinum(H) complexes entrapped in liposomes. KHOKHAR, A. R., AL-BAKER, S., KRAKOFF, I. H., and PEREZ-SOLER, R. Cancer Chemother. Pharmacol., 1989, 23, (4), 219–224.
  • Toxicity and antitumor activity of hydrophobic diammine and diaminocyclohexane platinum complexes entrapped in multilamellar vesicles. KHOKHAR, A. R., AL-BAKER, S., and PEREZ-SOLER, R. Anti-Cancer Drug. Des., 1988, 3, (3), 177–184.
  • Laser triggered release of a liposome-encapsulated dye for the qualitative and quantitative assessment of retinal circulation. KHOOBEHI, B., NIESMAN, M., PEYMAN, G., and ONCEL, M. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1980. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 368.
  • ESR study of proton transport across phospholipid vesicle membranes. KEIRAMTSOY, V. V., PANTELEEV, M. V., and WEINER, L. M. J. Biochem. Biophys. Methods, 1989, 18, (3), 237–246.
  • Intestinal absorption of dolichol from emulsions and liposomes in rats. KIMURA, T., TAKEDA, K., KAGEYU, A., TODA, M., KUROSAKI, Y., and NAKAYAMA, T. Chem. Pharm. Bull., 1989, 37, (2), 463–466.
  • Growth of baculovirus-infected insect cells in microcapsules to a high cell and virus density. KING, G. A., DAUGULIS, A. J., FAULKNER, P., BAYLY, D., and GoosEN, M. F. A. Biotechnol. Lett., 1988, 10, (10), 683–688.
  • Na- and Cl-dependent glycine transport in human red blood cells and ghosts. A study of the binding of substrates to the outward-facing carrier. KING, P. A., and GUNN, R. B. J. Gen. Physiol., 1989, 93, (2), 321–342.
  • Comparison of radiolabeled microsphere and Doppler echocardiographic determination of left ventricular output in the premature baboon. KINSELLA, J. P., MORROW, W. R., GERSTMANN, D. R., and DELEMOS, R. A. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989;3, (3), A874.
  • Liposome therapy; a novel approach to the treatment of childhood osteosarcoma. KLEINERMAN, E. S., and HUDSON, M. M. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 76–80.
  • The isolation and reconstitution of the ADP/ATP carrier from wild-type Saccharomyces cerevisiae. Identification of primarily one type (AAC-2). KNIRSCH, M., GAWAZ, M. P., and KLINGENBERG, M. FEBS Lett., 1989, 244, (2), 427–432.
  • Therapy for pulmonary infection by polysaccharide coated liposome. KOHNO, S. Med. Itnmunol., 1989, 17, (3), 307–311.
  • Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors. KONNO, H., KUMAI, K., TSUBOUCHI, T., ISHIBIKI, K., ABE, 0., TADAKUMA, T., YASUDA, T., NAGAIICE, K., HOSOKAWA, S., and SAKAGUCHI, S. Gan To Kagaku Ryoho, 1989, 16, (6), 2213–2217.
  • Antitumor effect of IL-2 entrapped in liposomes on rat hepatoma, AH-66. KONNO, H., TORIYAMA, H., AOKI, K., BABA, S., SAKAGUCHI, S., YAMASHITA, A., and TADAKUMA, T. GatI To Kagaku Ryoho, 1989, 16, (1), 53–58.
  • Interaction of the pore forming-peptide antibiotics Pep 5, main and subtilin with non-energized liposomes. KORDEL, M., SCHUELLER, F., and SAHL, H. G. FEBS Lett., 1989, 244, (1), 99–102.
  • Reconstitution of purified and functionally active dihydropyridine-sensitive calcium channel into liposomes. KOSTYUK, P. G., ROZHMANOVA, 0. M., STEL'MAKH, L. N., VORONINA, S. G., and SOLDATOV, N. M. Dokl. Akad. Nauk. SSSR, 1988, 301, (6), 1505–1507.
  • Shaking polystyrene beads during coating with antibody: effect on the precision profile of enzyme immunoassay of triiodothyronine (letter). KOTHARI, K., SIVAPRASAD, N., and MANI, R. S. Clin. Chem., 1989, 35, (4), 701.
  • Effect of liposomes on the adrenoreactivity of the papillary muscle. Komov, A. G., Los, G. V., and STEFANOV, A. V. Fixiol. Zh. SSSR, 1989, 75, (2), 200–204.
  • Monomeric and aggregated pyrene and 16-(1-pyrenyl)hexadecanoic acid in small, unilamellar phosphatidylcholine vesicles and ethanol-buffer solutions. L'HEUREUX, G. P., and FRAGATA, M. J. Photochem. Photobiol., B, 1989, 3, (I), 53–63.
  • A study on the dielectric constant of microcapsules during ageing. LABHASETWAR, V. D., Josm, S. V., and DORLE, A. K. J. Microencapsulation, 1988, 5, (4), 339–341.
  • Study of shellac glycerol esters as microencapsulating materials. LABHASETWAR, V. D., PURANIK, P. K., and DORLE, A. K. J. Microencapsulation, 1989, 6, (1), 115–118.
  • Photochemical targeting of phagocytic trabecular meshwork cells using chlorin e6 coupled microspheres. LATINA, M. A., KOBSA, P. H., RAKESTRAW, S. L., CREAN, E. A., HASAN, T., and YARMUSH, M. L. Proc. SPIE Int. Soc. Opt. Eng., 1989, 997 (Adv. Photochemother.), 32–41.
  • Antitumor activity of liposomal cis-bis-N-decylminodiacetato-1,2-diaminocyclo-hexaneplatinumaD against L1210 leukemia and metastases of M5076 murine reticulosarcoma. LAUTERSZTAIN, J., KHOKHAR, A. R., and PEREZ-SOLER, R. J. Liposorne Res., 1988, 1, (I), 1–13.
  • Complesing of bovine serum albumin with phosphatidylcholine liposomes. LEBED, 0. I., PRIMAK, R. G., and TISHCHENKO, R. I. Ukr. Biokhim. Zh., 1989, 61, (3), 101–106.
  • Periodic characteristics of composite membrane permeability. LEE, K. B., and LEE, Y. H. J. Microencapsulation, 1989, 6, (1), 59–70.
  • Quenching of fluorescence of pyrene-substituted lecithin by tetracyanoquinodimethane in liposomes. LEMMETYINEN, H., YLIPERTTULA, M., MIKKOLA, J., and KINNUNEN, P. Biophys. J 1989, 55, (5), 885–895.
  • MHC fully allogeneic bone transplantation after physical T-cell depletion with magnetic microspheres (MAMIS). LEYHAUSEN, G., WINOTO-MORBACH, S., BLANK, M., and MULLER-RucHHourz, W. Transplant. Proc., 1989, 21, (1, Pt. 3), 2943–2946.
  • Steady state and time-resolved fluorimetry of benzo(a)pyrene in liposomes and microsomes. Li, K. P., GLICK, M. R., INDRALINGAM, R., and WINEFORDNER, J. D. Spectrochim. Acta, Part A, 1989, 45, (4), 471–477.
  • The preparation, elasticity and proton/hydroxyl permeability of uniform, unilamellar vesicles of anionic phospholipids. Li WEI. City University of New York, New York, NY, USA, Dissertation, 1988, 162 pp.
  • Liposomes: preparation, characterization, and preservation. LICHTENBERG, D., and BARENHOLZ, Y. Methods Biochem. Anal., 1988, 33, 337–462.
  • In vitro and in vivo studies evaluating a liposome system for drug solubilization. LIDGATE, D. M., FELGNER, P. L., FLEITMAN, J. S., WHATLEY, J., and Fu, R. C. Pharm. Res., 1988, 5, (12), 759–764.
  • Introduction of microcapsules and application of microencapsulation. LIN, C. W., and CHEN, P. F. K'o Hsueh Nung Yeh (Taipei), 1989, 37, (3-4), 99–109.
  • Role of cholesterol in the stability of pH-sensitive, large unilamellar liposomes prepared by the detergent-dialysis method. Liu, D., and HUANG, L. Biochim. Biophys. Acta, 1989, 981, (2), 254–260.
  • Intravitreal liposome-bound cyclosporine treatment of experimental autoimmune uveitis in rats. Ltu, K. R., PEYMAN, G., NIKSMAN, M., KHOOBEHI, B., GEBHARDT, B., PALESTINE, A., and NUSSENBLATT, R. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 85.
  • Reduced toxicity of intravitreally injected liposome-encapsulated cytarabine. Liu, K. R., PEYMAN, G. A., SHE, S. C., NIESMAN, M. R., and KHOOBEHI, B. Ophthalmic. Surg., 1989, 20, (5), 358–361.
  • Transfer of phosphatidic acid from liposomes to cells is collision dependent. LONGMUIR, K. J., and MALINICK, L. A. Am. J. Physiol., 1989, 256, (3, Pt. 1), C522–531.
  • Treatment of systemic fungal infections with liposomal-amphotericin B. LOPEZ-BERESTEIN, G. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 317–328.
  • UCLA University of California-Los Angeles Symposia on Molecular and Cellular Biology New Series Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer Lake Tahoe California USA February 16–20 1988. LOPEZ-BERESTEIN, G., and FIDLER, I. J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY USA, publ. 1989.
  • Specific accumulation of technetium-99m radiolabelled, negative liposomes in the inflamed paws of rats with adjuvant induced arthritis: effect of liposome size. LOVE, W. G., Amos, N., KELLAWAY, I. W., and WILLIAMS, B. D. Ann. Rheum. Dis., 1989, 48, (2), 143–148.
  • Effect of liposome surface charge on the stability of technetium (99mTc) radiolabelled liposomes. LOVE, W. G., Amos, N., WILLIAMS, B. D., and KELLAWAY, I. W J. Microencapsulation, 1989, 6, (1), 105–113.
  • Dissolution rate of injection of microencapsulated compound megestrol acetate. Lu, B., MENG, J., XIE, Z., and Pu, J. Huaxi Yike Daxue Xuebao, 1989, 20, (1), 81–84.
  • Biological response modifications induced by adriaraycin or liposome encapsulated adriamycin. MACE, K. F. State University of New York, Buffalo, NY, USA, Dissertation, 1988, 183 pp.
  • Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated mummy tripeptide. MACEWEN, E. G., KURZMAN, I. D., ROSENTHAL, R. C., SMITH, B. W., MANLEY, P. A., ROUSH, J. K., and HOWARD, P. E. J. Natl. Cancer Inst., 1989, 81, (12), 935–938.
  • Spontaneous vesiculation of large multilamellar vesicles composed of saturated phosphatidylcholine and phosphatidylglycerol mixtures. MADDEN, T. D., Tmcocu, C. P., WONG, K., and CuLus, P. R., Biochemistry, 1988, 27, (24), 8724–8730.
  • Perfusion scintigraphy with technetium-99m-labeled microspheres to monitor implanted port systems prior to intraarterial cytostasis of liver metastases. MAULER, M., FRITSCH, S., FENZL, G., SCHALHORN, A., and MOSER, E. NuklearMedizin, 1988, 27, (5), 228–230.
  • Mechanism of protein-induced membrane fusion: fusion of phospholipid vesicles by clathrin associated with its membrane binding and conformational change. MAEZAWA, S., YOSHIMURA, T., HONG, K., DUZGUNECS, N., and PAPAHADJOPOULOS, D. Biochemistry, 1989,28, (3), 1422–1428.
  • Liposomes. Introduction to a new technology and description of preparative techniques. MAIERHOFER, G. Farm. Clin., 5, (9), 658, 661-662, 664-665, 668, 670, 673-674, 676-678, 680. Effects of plasma proteins on degradation properties of poly(L-lactide) microcapsules. MAKINO, K., OHSHIMA, H., and KoNoo, T. Pharm. Res., 1987, 4, (1), 62–65.
  • Scanning and transmission electron microscopy of biodegradable microspheres DSM in blood vessels. MAKITA, T., ICHIMAL, H., KAGABU, S., MANBA, K., NAITO, I., LINDBLOM, R., HATSUOKA, M., and OKAWA, T. Cell. Biol. Int. Rep., 1989, 13, (5), 427–436.
  • Influence of glycolipid oligosaccharide and long-chain base composition on the thermotropic properties of dipalmitoylphosphatidylcholine large unilamellar vesicles containing gangliosides. MASSERINI, M., PALESTINI, P., and FREIRE, E. Biochemistry, 1989, 28, (12), 5029–5034.
  • Polyamide microcapsules for controlled release. V. Photochemical release. MATHIOWITZ, E., and COHEN, M. D. J. Membr. Sci., 1989, 40, (1), 67–86.
  • Polyamide microcapsules for controlled release. IV. Effects of swelling. MATHIOWITZ, E., and COHEN, M. D. J. Membr. Sci., 1989, 40, (1), 55–65.
  • Polyamide microcapsules for controlled release. III. Spontaneous release of azobenzene. MATHIOWITZ, E., and COHEN, M. D. J. Membr. Sci., 1989, 40, (1), 43–54.
  • Polyamide microcapsules for controlled release. II. Release characteristics of the microcapsules. MATHIOWITZ, E., and COHEN, M. D. J. Membr. Sci., 1989, 40, (1), 27-41. Polyamide microcapsules for controlled release. I. Characterization of the membranes. MATHIOWITZ, E., and COHEN, M. D. J. Membr. Sci., 1989, 40, (1), 1–26.
  • Novel preparation of Zein microspheres conjugated with PS-K available for cancer immunotherapy. MATSUDA, Y., SUZUKI, T., SATO, E., SATO, M., KOIZUMI, S., UNNO, K., KATO, T., and NAKAI, K. Chem. Pharm. Bull., 1989, 37, (3), 757–759.
  • Analysis of dimensions and structural organization of proteoliposomes. MAYER, F., and ROHDE, M. Methods Microbiol., 1988, 20, 283–292.
  • Microencapsulated monosialoganglioside GMI: physical properties and in vivo effects. MAYSINGER, D., JALSENJAK, V., STOLNIK, S., GAROFALO, L., CUELLO, A. C., and JALSENJAK, I. J. Microencapsulation, 1989, 6, (1), 35–42.
  • Studies on the microencapsulation of rat pancreatic cell line AR 42J. MCCARTHY, U., MCHALE, A. P., and MCHALE, M. L. Biochem. Soc. Trans., 1989, 17, (2), 393–394.
  • The effect of hematoporphyrin derivative and human erythrocyte ghost-encapsulated hematoporphyrin derivative on a mouse myeloma cell line. MCHALE, A. P., MCHALE, M. L., and BLAU, W. Cancer Biochem. Biophys., 1988, 10, (2), 157–164.
  • Synthesis of chitosan-alginate microcapsule membranes. MCKNIGHT, C. A., Ku, A., GOOSEN, M. F. A., SUN, D., and PENNEY, C. J. Bioact. Compat. Polym., 1988, 3, (4), 334–355.
  • Incorporation of the nicotinic acetylcholine receptor into liposomes by rapid removal of detergent using polyethylene glycol 6000. MEDRANO, S., AGUILAR, J. S., RIVAS, E., and OCHOA, E. L. M. Neurochem. Int., 1989, 14, (1), 65–72.
  • Chromatographic studies of mitomycin C degradation in albumin microspheres. MEHTA, R. C., HOGAN, T. F., MARDMOMEN, S., and MA, J. K. J. Chromatogr., 1988, 430, (2), 341–349.
  • Effect of liposome encapsulation on toxicity and antifungal activity of polyene antibiotics. MEHTA, R. T., and LOPEZ-BERESTEIN, G. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 263–274.
  • Bioavailability of potassium from three dosage forms: suspension, capsule, and solution. MELIKIAN, A. P., CHENG, L. K., WRIGHT, G. J., COHEN, A., and BRUCE, R. E. J. Clin. Pharmacol., 1988, 28, (11), 1046–1050.
  • Effect of ET-18-0CH3/cholesterol liposomes on the membrane potential of isolated endothelial cells. MENDE, S., TEUSCHER, E., and LICHTNOW, K. H. Pharmazie, 1989, 44, (2), 164.
  • Interaction of tetanus toxin with lipid vesicles. Effects of pH, surface charge, and transmembrane potential on the kinetics of channel formation. MENESTRINA, G., FORTI, S., and GAMBALE, F. Biophys. J., 1989, 55, (3), 393–405.
  • Vesicle size: dependence on experimental parameters. MENGER, F. M., LEE, J. J., AIKENS, P., and DAVIS, S. J. Colloid Interface Sci., 1989, 129, (1), 185–191.
  • In vitro release and depot effect after intratumoral application of metrizamide-containing liposomes. MENTRUP, E., WOWRA, B., ZELLER, W. J., STURN, V., and STRICKER, H. Arzneim. Forsch., 1989, 39, (4), 421–423.
  • Liposomes as oral adjuvants. MICHALEK, S. M., CHILDERS, N. K., KATZ, J., DENYS, F. R., BERRY, A. K., ELDRIDGE, J. J., MCGHEE, J. R., and CURTISS, R. 3rd. Curt. Top. Microbiol. Immunol., 1989, 146, 51–58.
  • Treatment of brain trauma with liposomal superoxide dismutase. MICHELSON, A. M., JADOT, G., and PUGET, K. Free Radic. Res. Commun., 1988, 4, (4), 209–224.
  • Effects of free and liposornal amphotericin B and gramicidin S alone and in combination on potassium leakage from human erythrocytes and Candida albicans. MIDEZ, J. A., HOPFER, R. L., LOPEZ-BERESTEIN, G., and MEHTA, R. T. Antimicrob. Agents Chemother., 1989,33, (2), 152–155.
  • Liposome systems-promising dosage forms. Effect of the manufacturing approach on the size and uniformity of the liposome structures. MIKHAILOVA, S. Farmatsiya (Sofia), 1988, 38, (6), 24–30.
  • Interaction of the polyene antibiotic amphotericin B with model membranes: differences between small and large unilamellar vesicles. MILHAUD, J., HARTMANN, M. A., and BOLARD, J. Biochimie, 1989, 71, (1), 49–56.
  • Evidence from liposome encapsulation for transport-limited microbial metabolism of solid alkanes. MILLER, R. M., and BARTHA, R. Appl. Environ. Microbiol., 1989, 55, (2), 269–274.
  • Liposome encapsulation attenuates the pulmonary irritation caused by nicotine aerosol inhalation. MILLON, T. V., Wui, G. S., MUSTAFA, M. G., and ROSE, J. E. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisian, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1036.
  • Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. MONTE, P. D., and Szom, F. C. JR. J. Immunol., 1989, 142, (5), 1437–1443.
  • Effect of pH on the interaction of botulinum neurotoxins A, B and E with liposomes. MONTECUCCO, C., ScHiAvo, G., and DASGUPTA, B. R. Biochem. J., 1989, 259, (1), 47–53.
  • Effect of sodium nitroprusside and diazoxide on renal hemodynamics: a study with radioactive microspheres. MONTEIRO, J. L., SEGURO, A. C., CAMPOS, S. B., and ROCHA, A. S. Arq. Bras. Cardiol., 1988, 50, (5), 315–321.
  • Specific targeting and toxicity of sulphonated aluminium phthalocyanine photosensitised liposomes directed to cells by monoclonal antibody in vitro. MORGAN, J., GRAY, A. G., and HUEHNS, E. R. Br. J. Cancer, 1989, 59, (3), 366–370.
  • Suppressive effect of GABA-containing liposomes on kindled convulsion. MORI, N., TERAYAmA, K., SATO, T., and KUMASHIRO, H. Brain Nerve (Tokyo), 1989, 41, (2), 193–198.
  • Intravitreal drug delivery system using microspheres of biodegradable polymers. MORITERA, T., OGURA, Y., ARAI, M., HONDA, Y., WADE, R., HYON, S. H., and IKADA, Y. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 249.
  • Preparation of microcapsules from complex coacertation of Gantrez-gelatin. III. Bioavailability of nitrofurantoin microcapsules. MORTADA, S. A., EL-EGAKY, M. A., MOTAWI, A. M., and EL-KF1ODERY, K. A. J. Microencapsulation, 1988, 5, (4), 311–317.
  • Liposomes as bioreactors: transport phenomena in proteoliposomes. MOSSA, G., ANNESINI, M. C., DI-Gnmio, A., DINT, L., and FINAZZI-AGRO, A. Prog. Clin. Biol. Res., 1989, 292, 227–236.
  • Synergistic inhibition of oxidation in dispersed phosphatidylcholine liposomes by a combination of vitamin E and cysteine. MOTOYAMA, T., Milo, M., MINO, M., TAKAHASHI, M., and NIK1, E. Arch. Biochern. Biophys., 1989, 270, (2), 655–661.
  • Uptake of inert particles by dog alveolar macrophages in vitro: A comparison of monolayer and suspension techniques. MUELLER, H. L., GUILMETTE, R. A., and MUGGENBURG, B. A. J. Appl. Toxicol., 1989, 9, (3), 135–144.
  • Electron microscopic determination of liposomes in a cosmetic gel. MUELLER, T., ROED1NG, J., and LAUTENSCHLAEGER, H. Seifen, Oele, Fette, Wachse, 1989, 115, (3), 88–89.
  • Effect of propylgallate on a dipalmitoylphosphatidylglycerol and calcium mixture. MUKAI, K., and ISHINAGA, M. Chem. Phys. Lipids, 1989, 49, (4), 225–230.
  • Preparation and evaluation of polyglutaraldehyde nanoparticles containing 5-fluorouracil. MUKFIERJI, G., MURTHY, R. S. R., and MIGLANI, B. D. Int. J. Pharm., 1989, 50, (1), 15–19.
  • Studies on the effectiveness of hyperthermia combined with arterial therapeutic blockage in the treatment of tumors. Part 3. Clinical studies on the effectiveness of hyperthermia combined with arterial chemo-embolization using degradable starch microspheres (DSM). MURATA, T. Nippon Gan Chiryo Gakkai Shi, 1988, 23, (11), 2725–2731.
  • Studies on the effectiveness of hyperthermia combined with arterial therapeutic blockage in the treatment of tumors. Part 2. Experimental studies on the effectiveness of hyperthermia combined with arterial embolization using degradable starch microspheres (DSM). MURATA, T. Nippon Gan Chiryo Gakkai Shi, 1988, 23, (11), 2717–2724.
  • A pilot phase I trial of the liposomal ri-acetylmuramyl-L-alanylphosphatidylethanolamine, MTP-PE CGP- 1919835A, in cancer patients. MURRAY, J. L., KLEINERMAN, E. S., TATOM, J. R., CUNNINGHAM, J. E., LEPE-ZUNIGA, J., GUTTERMAN, J. U., ANDREJCIO, K., FIDLER, I. J., and KRAKOFF, I. H. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 329–342.
  • The immunological adjuvant activity of liposomes containing monophosphoryl lipid A and a synthetic analog of trehalose dimycolate. MYERS, K. R., WELTY, D. M., and ULRICH, J. T. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, (3) (3), A605.
  • Enhanced liposome-mediated antibacterial activity of piperacillin and gentamicin against gram-negative bacilli in vitro. NACUCCHIO, M. C., GATTO-BELLORA, M. J., SORDELLI, D. 0., and D'AQuiNo, M. J. Microencapsulation, 1988, 5, (4), 303–309.
  • Liposome composition and activation of macrophages for antimicrobial activities against leishmania parasites. NACY, C. A., GILBREATH, M. J., SWARTZ, G. M., MELTZER, M. S., and ALVING, C. R. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 167–176.
  • pH-Sensitive liposomes for the delivery of immunomodulators. NAYAR, R., and SCHROIT, A. J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 427–440.
  • Liposome-dependent delivery of ptericline antifolates: a two-compartment growth inhibition assay for evaluating drug leakage and metabolism. NG, K. Y., and HEATH, T. D. Biochim. Biophys. Acta, 1989, 981, (2), 261–268.
  • Prooxidant effect of Alpha-tocopheral (TC) in liposomes. NGUYEN, N., VIGO-PELFREY, C., and MARTIN, F. J. 155th National Meeting of the American Association for the Advancement of Science, San Francisco, California, USA, January 14–19. 1989. AAAS Publ., 1988, (88–30), 194.
  • Compatibility of liposome-encapsulated antimetabolites for intravitreal injection with silicone oil. NIESMAN, M., and PEYMAN, G. Annual Spring Meeting of the Association for Research in Vision and Ophthalmology, Sarasota, Florida, USA, April 30-May 5, 1989. Invest. Ophthalmol. Visual Sci., 1989, 30, (3, suppl.), 103.
  • Evaluation of permeation through polymeric membranes as a model for the release of drugs from gelatin-acacia walled microcapsules. NIXON, J. R., and WoNG, K. T. Int. J. Pharm., 1989, 50, (3), 205–212.
  • Preparation of microencapsulated liposomes, II. Systems containing nylon-gelatin, and nylon-gelatin-acacia walling material. NIXON, J. R., and YEUNG, V. W. J. Microencapsulation, 1989, 6, (1), 43–52.
  • Volume-sensitive, chloride-dependent potassium transport in resealed human erythrocyte ghosts. O'NEILL, W. C. Am. J. Physiol., 1989, 256, (1, Pt. 1), C81–C88.
  • In vivo release profiles of leuprolide acetate from microcapsules prepared with polylactic acids or copoly(lacticiglycolic) acids and in vivo degradation of these polymers. OGAWA, Y., OKADA, H., YAMAMOTO, M., and SHIMAMOTO, T. Chem. Pharm. Bull., 1988, 36, (7), 2576–2581.
  • Formulation factors of fenvalerate microcapsules influencing insecticidal efficacy and fish toxicity. OHTSUBO, T., TAKEDA, H., TSUDA, S., KAGOSHIMA, M., and Tsuji, K. J. Pestic. Sci., 1989, 14, (2), 235–240.
  • Preparation of micron-size monodisperse polymer microspheres having chloromethyl group. OKUBO, M., IKEGami, K., and Yamamoro, Y. Colloid Polym. Sci., 1989, 267, (3), 193-200. Methotrexate transport from the internal phase of multiple w/o/w emulsions. OMOTOSHO, J. A., WHATELEY, T. L., and FLORENCE, A. T. J. Microencapsulation, 1989, 6, (2), 183–192.
  • Antitumor effect of adriamycin entrapped in liposomes conjugated with anti-bovine tumor antigen monoclonal antibody in leukemic cows. ONUMA, M., YASUTOMI, Y., YAMAMOTO, M., WATARAI, S., YASUDA, T., and KAWAICAMI, Y. J. Vet. Med. Ser. B, 1989, 36, (2), 139–147.
  • Liposomes from the bench to the marketplace: Doxorubicin liposomes as an example. OSTRO, M. J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 155–164.
  • Retrovirus-induced lymphomatous mice with subsequent candidiasis treatment with free, and liposome-encapsulated daunorubicin and amphotericin B-1. PAL, B. K., ADLER, J. P., GUERRA, D. A., and PIERATOS, J. S. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 249–262.
  • Immunogenicity of ribonucleic acid-protein fraction of Mycobacterium tuberculosis encapsulated in liposomes. PANCHOLI, P., VINAYAK, V. K., and KHULLER, G. K. J. Med. Microbiol., 1989, 29, (2), 131–138.
  • Liposomes in drug delivery from serendipity to tumor targeting. PAPAHADJOPOULOS, D., LOPEZ, N., and GaatzoN, A. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 135–154.
  • Evaluation of compressibility of pentaestergum coated aspirin microcapsules. PATHAK, Y. V., and DORLE, A. K. J. Microencapsulation, 1989, 6, (2), 199–203.
  • Translation of liposome delivered messenger RNA; chromatin structure at the origin region of simian virus 40. PAXTON, W. B. Health Sciences Center, University of Illinois, Chicago, II, USA, Dissertation, 1988, 337 pp.
  • Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. PEETERS, P. A., BRUNINK, B. G., ELING, W. M., and CROMMELIN, D. J. Biochim. Biophys. Acta, 1989, 981, (2), 269–276.
  • Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecrumato- trans-R,R-1,2-diarninocyclohexane platinum(II). PEREZ-SOLER, R., LAUTERSZTAIN, J., STEPHENS, L. C., WRIGHT, K., and KHOKHAR, A. R. Cancer Chemother. Pharmacol., 1989, 24, (1), 1–8.
  • Design and development of liposome-dependent antitumor agents. PEREZ-SOLER, R., LOPEZ-BERESTEIN, G., and KHOKHAR, A. R. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 59–70.
  • Clearance of phosphatidylcholine, and cholesterol from liposomes, liposomes loaded with metaproterenol,, and rabbit surfactant from adult rabbit lungs. PETTENAZZO, A., Ram, A., IKEGAMI, M., ABRA, R., HOGUE, E., and MIHALKO, P. Am. Rev. Respir. Dis., 1989, 139, (3), 752–758.
  • Intravitreal liposome-encapsulated drugs: a preliminary human report. PEYMAN, G. A., CHARLES, H. C., Liu, K. R., KHOOBEHI, B., and NIESMAN, M. Int. Ophthalmol., 1988, 12, (3), 175–182.
  • Experimental and clinical evaluation of liposome-tumor antigen immunotherapy. PHILLIPS, N. C., LOUTFI, A., KAREEM, M., SHIBATA, H., and BAINES, M. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 15–24.
  • Inhibition of experimental liver tumor growth in mice by liposomes containing a liphophilic muramyl dipeptide derivative. PHILLIPS, N. C., and TSAO, M. S. Cancer Res., 1989, 49, (4), 936–939.
  • The oxidative interaction of hemoglobin and lipid microspheres. PIETRZAK, W. University of Illinois, Chicago, IL, USA, Dissertation, 1988, 246 pp.
  • Selective depletion of macrophages using toxins encapsulated in liposomes effect on antimicrobial resistance. PINTO, A. J., STEWART, D., VOLKMAN, A., JENDRASIAK, G., VAN-RomjEN, N., and MORAHAN, P. S. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 441–452.
  • Liposome-encapsulated antifibrotic agent prevents early hypoxic pulmonary hypertension in the rat. POIANI, G. J., SUMKA, J. M., Tozzi, C. A., SANTIAGO, A. L., LIAO, W. C., and RILEY, D. J. Annual Meeting of the American Lung Association and the American Thoracic Society, Cincinnati, Ohio, USA, May 14–17. 1989. Am. Rev. Respir. Die., 1989, 139, (4, part 2), A172, Formation and in vitro evaluation of theophylline-loaded poly(methyl methacrylate) microspheres. PONGPAIBUL, Y., MARUYAMA, K., and IWATSURA, M. J. Pharm. Pharntacol., 1988, 40, (8), 530–533.
  • Inhibition of HIV replication by liposomal encapsulated amphotericin B. PONTANI, D. R., SUN, D., BROWN, J. W., SHAHIED, S. I., PLESCIA, 0. J., SCHAFFNER, C. P., LOPEZ-BERESTEIN, G., and SARIN, P. S. Antiviral. Res., 1989, 11, (3), 119–125.
  • Microencapsulation of phenylpropanolarnine to achieve sustained release. PRAPAITRAKUL, W., and WHITWORTH, C. W. J. Microencapsulation, 1989, 6, (2), 213–218.
  • Time-related changes in microsphere entrapment in canine jejunum. PROKOPIW, I., DINDA, P. K., and BECK, I. T. Am. J. Physiol., 1989, 256, (3, Pt. 1), C451-C457. Phytosomes: cosmetic applications. PROSERPIO, G., and FERRARIS, S. Cosmet. Toiletries, Ed. Ital., 1988, 9, (5), 6–7. 10–11. 14.
  • Comparison of steady-state fluorescence polarization and urea permeability of phosphatidylcholine and phosphatidylsulfocholine liposomes as a function of sterol structure. PUGH, E. L., BITTMAN, R., FUGLER, L., and KATES, M. Chem. Phys. Lipids, 1989, 50, (1), 43–50.
  • The influence of fatty acyl chain length and head group in the size of multilamellar vesicles. RACEY, T. J., SINGER, M. A., FINEGOLD, L. and ROCHON, P. Chem. Phys. Lipids, 1989, 49, (4), 271–288.
  • Preclinical and clinical pharmacology of doxorubicin entrapped in cardiolipin liposomes. RAHMAN, A., Roe, J. K., and TREAT, J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 367–390.
  • Microcapsules and composite dosage forms of sulfamethoxydiazine with controlled release of the active substance. RAK, J., CHALABALA, M., and VITKOVA, M. Acta FaC, Pharm. Univ. Comenianae, 1987, 41, 23–62.
  • Composite potassium chloride tablets from ethyl cellulose microcapsules. RAK, J., CHALABALA, M., and VITKOVA, M. Acta Fac. Pharm. Univ. Comemianae, 1987, 41, 5–22.
  • The effect of gentamicin on the biophysical properties of phosphatidic acid liposomes is influenced by the 0- C = 0 group of the lipid. RAMSAMMY, L. S., and KALOYANIDES, G. J. Biochemistry, 1988, 27, (21), 8249–8254.
  • The photophysical properties of porphycene incorporated in small unilamellar lipid vesicles. REDMOND, R. W., VALDUGA, G., NONELL, S., BRASLAVSKY, S. E., SCHAFFNER, K., VOGEL, E., PRAMOD, K., and KOECHER, M. J. Photochem. Photobiol., B, 1989, 3, (2), 193–207.
  • Effect of encapsulating thiocarbamate herbicides within starch for overcoming enhanced degradation in soils. REED, J. P., HALL, F. R., and TRIMNELL, D. Starch Staerke, 1989, 41, (5), 184–186.
  • Controlled release of drugs, polymers and aggregate systems. ROSOFF, M. M. Rosoff (Ed.). Controlled Release of Drugs: Polymers and Aggregate Systems. VCH Verlagsgesellschaft, Weinheim, West Germany, 1989, 315 p.
  • Ocular blod flow in dogs using radiolabelled microspheres. ROY, M. S., HARRISON, K. S., HARVEY, E., and MITCHELL, T. Int. J. Rad. Appl. Instrum. (B), 1989, 16, (1), 81–84.
  • Volume-sensitive K influx in human red cell ghosts. SACHS, J. R. J. Gen. Physiol., 1988, 92, (5), 685–711.
  • Therapeutic efficacy of liposome-entrapped rifampin against Mycobacterium avium complex infection induced in mice. SAITO, H., and TommicA, H. Antimicrob. Agents Chemother., 1989, 33, (4), 429–433.
  • Preparation of microcapsules containing water solution as core material. SAKAKI, K., HATATE, Y., HASFIIGUCHI, T., 'KARI, A., and NAKASHIO, F. Kagoshima Daigaku Kogakubu Kenkyu Hokoku, 1988, (30), 165–170.
  • Study of the dependence of properties of a fireproofmg compound in an epoxy resin shell on microencapsulation conditions. SAMOKHVALOV, E. P., 1211.0, R. P., ZAVERACH, M. M., and REDIK, R. I. Bromorgan Soed Antipireny, M P: 1988, 7–13.
  • Studies on microencapsulation of cardamom oil by a spray drying technique. SANKARIKUTTY, 13., SREEKUMAR, M. M., NARAYANAN, C. S., and MATHEW, A. G. J. Food Sci. Technol., 1988, 25, (6), 352–356.
  • Study of myocardial perfusion at rest using technetium Tc-99m methoxy-isobutylisonitrile: comparison with labeled microspheres and thallium-201. SANTORO, G. M., Bist, G., SCIAGRA, R., ANTONIUCCI, D., DE-CRISTOFARO, M. T., DOVELLINI, E. V., PUPI, A., ZERAUSCHEK, M., and FAZZINI, P. F. G. Ital. Cardiol., 1988, 18, (11), 907–913.
  • Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. SATO, T., KANKE, M., SCHROEDER, H. G., and DELucA, P. P. Pharm. Res. 1988, 5, (1), 21–30.
  • Drug targeting using albumin microspheres. SAUNDERS, J. E. University of Nottingham, Nottingham, UK, Dissertation, 1988, 342 pp.
  • The preparation and characterization of lipid vesicles containing esters of sucrose and fatty acids. SCHENK, P., AUSBORN, M., BENDAS, F., NUHN, P., ARNDT, D., and MEYER, H. W J. Microencapsulation, 1989, 6, (1), 95–103.
  • Targeting of liposomes to liver cells. SCHERPHOF, G. L., SPANJER, H. H., DERKSEN, J. T., LAZAR, G., and ROERDINK, F. H. Horiz. Biochem. Biophys., 1989, 9, 281–291.
  • Liposome-cell interactions in vitro, and in vivo. Effects of surface charge, cholesterol, and gadolinium chloride. SCHERPHOF, G. L., DIJKSTRA, J., LAZAR, G., and ROERDINK, F. H. Stud. Biophys., 1989, 128, (3), 145–154.
  • Drug transport through artificial lipoid membranes. 22. Amplitude of ultrasonicated liposomes as a model system for investigations of drug transport. SCHNEIDER, S., GRUNDNER, S., NEUBERT, R., and FURST, W. Pharmazie, 1988, 43, (9), 630–631.
  • Antibody cell-targeting of liposomes carrying ara C derivatives. SCHOTT, H., HESS, W., LEITNER, B., and SCHWENDENER, R. A. Nucleosides Nucleotides, 1988, 7, (5-6), 721–723.
  • Coupling of monoclonal antibodies with carboxylated liposomes carrying N4-oleoyl-ara C. SCHOTT, H., HESS, W., and SCHWENDENER, R. A. Labor. Med., 1988, 11, (12), 698, 701–702.
  • Structural changes in vesicle membranes and mixed micelles of various lipid compositions after binding of different bile salts. SCHUBERT, R., and SCHMIDT, K. H. Biochemistry, 1988,27, (24), 8787–8794.
  • Comparison of free and liposomal MIP-PE pharmacological toxicological and pharmacokinetic aspects. SCHUMANN, G., VAN-HOOGEVEST, P., FANKHAUSER, P., PROBST, A., PELL, A., COURT, M., SCHAFFNER, J. C., FISCHER, M., SKRIPSKY, T., and GRAEPEL, P. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 191–204.
  • Treatment of acute myelogenous leukaemia with liposomes containing N-4 oleykytosine arabinoside. SCHWENDENER, R., PESTALOZZI, B., BERGER, S., SCHOTT, H., HENGARTNER, H., and SAUTER, C. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 95–104.
  • Small unilamellar liposomes as magnetic resonance contrast agents loaded with paramagnetic manganese-, gadolinium-, and iron-DTPA-stearate complexes. SCHWENDENER, R. A., WUETHRICH, R., DUEWELL, S., WESTERA, G., and VON-SCHULTHESS, G. K. Int. J. Pharm., 1989, 49, (3), 249–259.
  • Water-insoluble drugs entrapped into sonicated liposomes, intravenous administration of large volumes in cancer patients, phase-I studies. SCULIER, J. P., COUNT', A., BRASSINNE, C., LADURON, C., HOLLAERT, C., and ATASSI, G. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 343–352.
  • The role of liposomes in diagnostic imaging. SELTZER, S. E. Radiology, 1989, 171, (1), 19–21.
  • Dehydration-rehydration vesicle methodology facilitates a novel approach to antibody binding to liposomes. SENIOR, 3., and GREGORIADIS, G. Biochim. Biophys. Acta, 1989, 1003, (1), 58–62.
  • Liposomes facilitate uptake of lipid-soluble vitamins after oral delivery to normal and bile-duct obstructed rats. SENIOR, J. H., GREGORIADIS, G., MULLER, D. P. R., PATHAK, Y. V., and MCINTYFtE, N. 627th Annual Meeting of the Biochemical Society, Nottingham, England, UK. Biochem. Soc. Trans., 1989, 17, (1), 121–122.
  • Spontaneous formation of giant phospholipid vesicles. SERVUSS, R. M. Z. Naturforsch., C: Biosci., 1988, 43, (11-12), 938–947.
  • Microencapsulated anticancer drug. Experimental studies on microencapsulation of peplomycin and application to arterial microchemoembolization. SHINDO, M., Akita Igaku, 1988, 15, (3), 531–541.
  • Studies on oral administration of liposomal insulin. Its absorption, metabolism, and hypoglycemic effects. SHIRANE, K. Keio Igaku, 1989, 66, (1), 17–25.
  • The investigation of dual-wavelength spectroscopy for the analysis of dissolved drug in microcapsule suspensions. SHIVELY, M. L., and SIMONELLI, A. P. Int. J. Pharm., 1989, 50, (1), 39–43.
  • Effect of drug core particle size on the dissolution of theophylline from microspheres made from low molecular weight cellulose acetate propionate. SHUKLA, A. J., and PRICE, J. C. Pharm. Res. (NY), 1989, 6, (53), 418–421.
  • Determination of glycolytic intermediates in a flow injection system using immobilized enzymes. SIMON, L. M., KOTORMAN, M., BOROSS, L., and SZAJANI, B. Acta Biochim. Biophys. Hung., 1988, 23, (3-4), 247–254.
  • Liposomes as carriers of enviroxime for use in aerosol therapy of rhinovirus infections. Six, H. R., GILBERT, B. E., WYDE, P. R., WILSON, S. Z., and KNIGHT, V. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 229–238.
  • Nanosphere-coupled and liposome-entrapped anthracyclines: Potential intracavity therapeutics. SMITH, M. I., FORSSEN, E., DUBEAU, L., JoNEs, P., MUGGIA, F. M., and TOKES, Z. Annual Meeting of the Western Society for Clinical Investigation, Carmel, California, USA, February 7–10. 1989. Clin. Res., 1989, 37, (1), 163A.
  • The new liposome generation. SOEHNLEIN, H. S., and BRUNKE, R. A. Seifen, Oele, Fette, Wachse, 1989, 115, (3), 85–87.
  • Quantitation of calcium uptake by Arsenazo III-loaded liposomes. SOKOLOVE, P. M., and KESTER, M. B. Anal. Biochem., 1989, 177, (2), 402–406.
  • Human monocyte activation to the tumoricidal state by liposome-encapsulated muramyl tripeptide and its therapeutic implication. SONE, S. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 125–134.
  • Accelerated ripening of Gouda cheese made from ultrafiltered milk using a liposome entrapped enzyme and freeze shocked Lactobacilli. SPANGLER, P. L., EL-SODA, M., JOHNSON, M. E., OLsoN, N. F., AMUNDSON, C. H., and HILL, C. G. JR. Milchtvissenschaft, 1989, 44, (4), 199–203.
  • Biodegradable microparticles for delivery of polypeptides and proteins. SPENLEHAUER, G., SPENLEHAUER-BONTHONNEAU, F., and TRIES, C. Prog. Clin. Biol. Res., 1989, 292, 283–291.
  • Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes. STEGMANN, T., NIR, S., and WILSCHUT, J. Biochemistry, 1989, 28, (4), 1698–1704.
  • Biodegradable microspheres. XII: Properties of the crosslinking chains in polyacryl starch microparticles. STJARNKVIST, P., LAAKSO, T., and SJOHOLM, I. J. Pharm. Sci., 1989, 78, (1), 52–56.
  • Studies on the mode of action of dozorubicin-liposomes. STORM, G., NASSANDER, U. K., ROERDINK, F. H., STEERENBERG, P. A., DE-JONG, W. H., and CROMMELIN, D. J. A. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 105–116.
  • Potential pitfalls in in vitro antitumor activity testing of free and liposome-entrapped dozorubicin. STORM, G., STEERENBERG, P. A., VAN-BORSSUM-WAALICES, M., EMMEN, F., and CROMMELIN, D. J. J. Pharm. Sci., 1988, 77, (10), 823–830.
  • Iron binding to alpha-tocopherol-containing phospholipid liposomes. STOYANOVSKY, D. A., KAGAN, V. E., and PACKER, L. Biochem. Biophys. Res. Commun., 1989, 160, (2), 834-838. Study of the stabilization of liposomes with encapsulated procaine hydrochloride. STOZEK, T. Acta Pharm. Jugosl., 1988, 38, (4), 307–313.
  • Liposomes as cyclosporin A carriers: positively charged lecithin-cholesterol liposomes associated with cyclosporin A do not inhibit biosynthesis of mitochondrial polyglycerophosphatides and microsomal phosphatidylinositol. STUHNE-SEKALEC, L., and STANACEV, N. Z. J. Microencapsulation, 1989, 6, (2), 177–182.
  • The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen. Su, D., and VAN-RooljEN, N. Immunology, 1989,66, (3), 466–470.
  • Preparation of zein microspheres conjugated with antitumor drugs available for selective cancer chemotherapy and development of a simple colorimetric determination of drugs in microspheres. SUZUKI, T., SATO, E., MATSUDA, Y., TADA, H., UNNO, K., and KATO, T. Chem. Pharm. Bull., 1989, 37, (4), 1051–1054.
  • Some structural and functional properties of hemoglobin-containing liposomes (hemosomes), a potential red blood cell substitute. SZEBENI, J., DI-Iogto, E. E., HAUSER, H., and WINTERFIALTER, K. H. Adv. Exp. Med. Biol., 1988, 238, 199–208.
  • Entrapment of high-molecular-mass DNA molecules in liposomes for the genetic transformation of animal cells. SZELEI, J., and DUDA, E. Biochem. J., 1989, 259, (2), 549-553. Efficient transformation of animal cells with liposomes of high DNA density. SZELEI, J., and DUDA, E. Biol. ZentraMl., 1989, 108, (1), 25–29.
  • Effect of pilocarpine hydrochloride liposomes on the intraocular pressure and the rabbit eye pupil. SzuLc, J., WoYcztKowsgt, B., and DE-LAVAL, W. Farm. Pol., 1988, 44, (8), 462-465. Synthesis of gelatin microspheres containing interferon. TABATA, Y., and IKADA, Y. Pharm. Res. (NY), 1989, 6, (53), 422–427.
  • Macrophage activation for antitumor function by a muramyl dipeptide derivative encapsulated in polylactide microspheres. TABATA, Y., and IKADA, Y. C. De Putter et al. (Eds). Advances in Biomaterials, Vol. 8. Implant Materials in Biofunction; Seventh European Conference on Biomaterials, Amsterdam, Netherlands, September 8–11. 1987, 508 p, Elsevier, Amsterdam, Netherlands, publ. 1988, pp. 263–268.
  • Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation. TABATA, Y., and IKADA, Y. Pharm. Res., 1989, 6, (4), 296–301.
  • In vivo effects of recombinant interferon alpha A/D incorporated in gelatin microspheres on murine tumor cell growth. TABATA, Y., UNO, K., MURAMATSU, S., and IKADA, Y. Jpn J. Cancer Res., 1989, 80, (4), 387–393.
  • Artificial fiavolipid: Its synthesis, incorporation into liposomal membrane electron transport, and successful control of transport rate. TABUSHI, I., HAMACHI, I., and KOBUKE, Y. J. Chem. Soc. Perkin. Trans. I, 1989, (3), 383–390.
  • Fundamental studies of targeting cancer chemotherapy against choriocarcinoma-application of liposome. TADERA, S., YAMANAKA, N., and KAMIDONO, S. Hinyokika Kiyo, 1989, 35, (2), 209–215.
  • Diene-containing lipids as probes for phase-transition behavior of lipids in liposomes. TAKEOKA, S., IWAI, H., OHNO, H., and TSUCHIDA, E. Bull. Chem. Soc. Jpn, 1989, 62, (1), 102–108.
  • The size reduction of liposomes with a high pressure homogenizer (Microfiuidizer). Characterization of prepared dispersions and comparison with conventional methods. TALSMA, H., OZER, A. Y., VAN-BLOOIS, L., and CROMMELIN, D. J. A. Drug. Dev. Ind. Pharm., 1989, 15, (2), 197–207.
  • Studies of fluorescence depolarization at high pressures of dimyristoylphosphatidylcholine liposomes containing poly(gamma-benzyl-L-glutamate). TAMURA, K., HIGASHI, Y., and Suzum, A. Chem. Phys. Lipids, 1988, 48, (3-4), 169–175.
  • Incorporation of reconstituted influenza virus envelopes into liposomes: studies of the immune response in mice. TAN, L., LOYTER, A., and GREGORIADIS, G. Biochem. Soc. Trans., 1989, 17, (1), 129–130.
  • In vitro targeting and cytotoxicity of adriamycin in liposomes bearing monoclonal antibody against rat or human gp125 cell proliferation-associated antigen. TANAKA, T., Suzuki, S., MASUKO, T., and HASHIMOTO, Y. Jpn J. Cancer Res., 1989, 80, (4), 380–386.
  • Radiopaque hydrogel microspheres. THANOO, B. C., and JAYAKRISHNAN, A. J. Microencapsulation, 1989, 6, (2), 233–244.
  • Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake. Thom, A. K., SIGURDSON, E. R., 131TAR, M., and DALY, J. M. Surgery, 1989, 105, (3), 383–392.
  • Temperature-dependent insertion of prolipoprotein into Escherichia coli membrane vesicles, and requirements for ATP, soluble factors,, and functional SecY protein for the overall translocation process. TIAN, G., Wu, H. C., RAY, P. H., and TAI, P. C. J. Bacteriol., 1989, 171, (4), 1987–1997.
  • Liposomal Gd-DTPA: preparation and characterization of relaxivity. TILCOCK, C., UNGER, E., CuLus, P., and MACDOUGALL, P. Radiology, 1989, 171, (1), 77–80.
  • Non-leaky vesiculation of large unilamellar vesicles (L1UV) induced by plasma high density lipoproteins (HDL): detection by HPLC. TISCHLER, U., RUCKERT, D., SCHUBERT, R., JARONI, H. W., and SCHMIDT, K. H. Biochem. Biophys. Res. Commun., 1989, 160, (3), 1219–1226.
  • Liposomal sustained-release delivery systems for intravenous injection V. Biological disposition of liposome-entrapped lipophilic prodrug of 1-beta-n-arabinofuranosylcytosine. TOKUNAGA, Y., IwAsA, T., FUJISAKI, J., SAWAI, S., and KAGAYAMA, A. Chem. Pharm. Bull., 1988, 36, (10), 4060–4067.
  • Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-beta-n-arabinofuranosylcytosine prodrug-bearing liposomes. TOKUNAGA, Y., IwAsA, T., FUJISAKI, J., SAWAI, S., and KAGAYAMA, A. Chem. Pharm. Bull., 1988, 36, (9), 3574–3583.
  • Liposomal sustained-release delivery systems for intravenous injection. III. Antitumor activity of lipophilic mitomycin C prodrug-bearing liposomes. TOKUNAGA, Y., IwAsA, T., Evils/tic', J., SAWAI, S., and KAGAYAMA, A. Chem. Pharm. Bull., 1988, 36, (9), 3565–3573.
  • Liposomal sustained-release delivery systems for intravenous injection. II. Design of liposome carriers and blood disposition of lipophilic mitomycin C prodrug-bearing liposomes. TOKUNAGA, Y., IWASA, T., FUJISAKI, J., SAWAI, S., and KAGAYAMA, A. Chem. Pharm. Bull., 1988, 36, (9), 3557–3564.
  • Liposomal sustained-release delivery systems for intravenous injection. I. Physicochemical and biological properties of newly synthesized lipophilic derivatives of mitomycin C. TOKUNAGA, Y., IwAsA, T., Fujismu, J., SAWAI, S., and KAGAYAMA, A. Chem. Pharm. Bull. (Tokyo), 1988, 36, (8), 3060–3069.
  • Temperature-sensitive release of adriamycin, an amphiphilic antitumor agent, from dipalmitoylphosphatidylcholine-cholesterol liposomes. TOMITA, T., WATANABE, M., TAKAHASHI, T., KUMAI, K., TADAKUMA, T., and YASUDA, T. Biochim. Biophys. Ada, 1989, 978, (2), 185–190.
  • Microencapsulation of active substances. I. Characterization of polymer films for coating. TOMOVA, V., SHOPOVA, S., VELIKOVA, E., and STANOEVA, L. Farmatsiya (Sofia), 1988, 38, (6), 37–42.
  • Paracetamol microencapsulation in egg albumin. TORRADO, D. J. J. An. R. Acad. Farm., 1988,54, (4), 604–612.
  • Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. TORRADO, J. J., ILLum, L., and DAVIS, S. S. Int. J. Pharm., 1989, 51, (1), 85–93.
  • Liposome encapsulated doxorubicin preliminary results of phase I and phase II trials. TREAT, J., GREENSPAN, A. R., and RAHMAN, A. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 353–366.
  • Pharmacokinetic assessment of acetylated Pullulan microcapsules containing oral cephem antibiotics using beagle dogs. UCHIDA, T., FUJIMOTO, I., and GOTO, S. Yakuzaigaku, 1989,49, (1), 53–58.
  • Biopharmaceutical evaluation of sustained-release ethylcellulose microcapsules containing cefadroxil and cephradine using beagle dogs. UCHIDA, T., and GOTO, S. Chem. Pharm. Bull., 1988, 36, (6), 2135–2144.
  • Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging. UNGER, E. C., WINOKUR, T., MACDOUGALL, P., ROSENBLUM, J., CLAIR, M., GATENBY, R., and TmcocR, C. Radiology, 1989, 171, (1), 81–85.
  • Stimulation of monocyte cytotoxicity and interleukin 1 IL-1 release and platelet aggregation by soluble S and liposomal 1 platelet-activating factor. VALONE, F. H., DEBS, R. J., BARTHELSON, R. A., and PHILIP, R. 73rd Annual Meeting of the Federation of American Societies for Experimental Biology, New Orleans, Louisiana, USA, March 19–23. 1989. FASEB Fed. Am. Soc. Exp. Biol. J., 1989, 3, (4), A1336.
  • Growth of rat mammary tumor line 64-24 in liposome-supplemented defined medium. II. Effect of liposome B and prolactin on colony forming efficiency. VAN-DER-HAEGEN, B. A., HAM, R. G., and ICANo-StmoKA, T. In Vitro Cell Dev. Biol., 1989, 25, (2), 158–162.
  • Growth of rat mammary tumor line 64-24 in liposome-supplemented defined medium. I. Effect of liposome B components on colony growth. VAN-DER-HAEGEN, B. A., HAM, R. G., and KANO-SUEOKA, T. In Vitro Cell Dev. Biol., 1989, 25, (2), 151–157.
  • An industrial liposomal dosage form for muramyl-tripeptide-phosphatidylethanolamine (MTP-PE). VAN-HOOGEVEST, P., and FANKHAUSER, P. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 453–466.
  • Use of leptospiral microcapsular antigens for the detection of specific antibodies. VOLINA, E. G., ARIMITSU, E., KOBAIASHI, S., KIKTENKO, V. S., and TKACHENKO, E. A. Zh. Mikrobiol. Epidemiol. Immunobiol., 1988, (11), 90–94.
  • Pharmacokinetics and drug distribution of MTX polyphase liposome. WAN-JIANSHENG, TAO-JUN, MA-ZHUQING, and GU-XuEQiu. Shenyang Yaoxueyuan Xuebao, 1989, 6, (2), 89-94. Porphinato zinc complexes incorporated into the bilayer membrane of lipid liposomes. WANG, L., TAKAHASHI, T., ONO, H., and TSUCHIDA, E. J. Macromol, Sci., Chem., A26, (2-3), 481-493. Electrodynamic radioactivity detector for microparticles. WARD, T. L., DAVIS, E. J., J ENKINS, R. W. JR, and McRAE, D. D. Rev. Sci, Instrum., 1989, 60, (3), 414–421.
  • Membrane stabilization by vitamin E: magnetic resonance studies of the interaction of alpha-tocopherol with fatty acid acyl chains in phospholipid model membranes. WASSALL, S. R., PHELPS, T. M., WANG, L., LANGSFORD, C. A., and STILLWELL, W. Prog. Clin. Biol. Res., 1989, 292, (Biol. Synth. Membr.), 435–444.
  • Prostaglandin and thromboxane in liposomes: suppression of the primary immune response to liposomal antigens. WASSEF, N. M., RICHARDS, R. L., HAYRE, M. D., and ALVING, C. R. Biochem. Biophys. Res. Commun., 1989, 160, (2), 565–572.
  • Stability in biological fluids and clearance of immunoliposomes. WECKENMANN, H. P., MATZKU, S., STRICICER, H., and SINN, H., Arzneim Forsch., 1989, 39, (3), 415–420.
  • Commercial approaches to the delivery of macromolecular drugs with liposomes. WEINER, A. L., CANNON, J. B., and TYLE, P. M. Rossoff (Ed.). Controlled Release of Drugs: Polymers and Aggregate Systems, 315 p, VCH Verlagsgesellschaft, Weinheim, West Germany, publ. 1989, pp. 217–254.
  • Aluminum-altered membrane dynamics in human red blood cell white ghosts. WEIS, C., and HAUG, A. Thromb. Res., 1989, 54, (2), 141–149.
  • Covalent coupling of sugars to liposomes. WEISSIG, V., LASCH, J., and GREGORIADIS, G. Biochim. Biophys. Acta, 1989, 1003, (1), 54–57.
  • Protein I of Neisseria gonorrhoeae as an immunogen; Liposomes, proteosomes and lack of blocking antibody production. WETZLER, L. M., BLARE, M. S., KOOMEY, J. M., and GOTSCHLICH, E. C. National Meeting of the Association of American Physicians, Washington, D.C., USA, April 28-May 1, 1989. Clin. Res., 1989, 37, (2), 609A.
  • Membrane-derived microparticles supporting assembly of the prothrombinase enzyme complex are reduced in congenital platelet procoagulant deficiency Scott syndrome. WIEDMER, T., Sims, P. J., WEISS, H. J., ESMON, C. T., and SHATTIL, S. J. National Meeting of the Association of American Physicians, Washington, D.C., USA, April 28-May 1, 1989. Clin. Res., 1989, 37, (2), 603A.
  • Molecular mechanisms of membrane fusion and applications of membrane fusion techniques. WILSCHUT, J., SCHOLMA, J., and STEGMANN, T. Adv. Exp. Med. Biol., 1988, 238, 105–126.
  • Magnetic microspheres (MMS) coupled to selective lectins: a new tool for large-scale extraction and purification of human pancreatic islets. WINOTO-MORBACH, S., LEYHAUSEN, G., SCHUNKE, M., ULRICHS, K., and MULLER-RUCHHOLTZ, W. Transplant. Proc., 1989, 21, (1, Pt. 3), 2628–2630.
  • A lipid vesicle system for probing voltage-dependent peptide-lipid interactions: application to alamethicin channel formation. WOOLLEY, G. A., and DEBER, C. M. Biopolymers, 1989, 28, (1), 267–272.
  • Targeting of colloidal drug carriers. WRIGHT, J. J. University of Nottingham, Nottingham, UK, Dissertation, 1988, 309 pp.
  • Potentiometric enzyme-amplified flow injection analysis: detection system behavior of free and liposome-released peroxidase. Wu, T. G., BELLAMA, J. M., and DURST, R. A. Anal. Lett., 1989, 22, (5), 1107–1124.
  • Preparation of adenosine triphosphate (ATP) liposomes. Xu, G. X., and XIE, X. H. Yaoxue Xuebao, 1989, 24, (2), 133–138.
  • Selective transfer of cyclosporin to thoracic lymphatic systems by the application of lipid microspheres. YANAGAWA, A., IWAYAMA, T., SAOTOME, T., SHOJI, Y TAKANO, K., OKA, H., NAKAGAWA, T., and MIZUSHIMA, Y. J. Microencapsulation, 1989, 6, (2), 161–164.
  • Morphological and functional studies on microencapsulated human fetal pancreatic tissue. YANG HUA, and Wu ZHAOGUANG. Shanghai Yike Daxue Xuebao, 1988, 15, (5), 321–325.
  • Immunoassay using fluorescent dye-trapped liposomes. Liposome immune lysis assay (LILA). YASUDA, T., IsHimoru, Y., and UMEDA, M. Nonisot Immunoassay, Plenum, New York, NY, USA, 1988, pp. 389–399. Ed: Ngo, T. T.
  • Treatment of mice infected orally with Salmonella dublin using a stable gentamicin liposome formulation. YAU-YOUNG, A., HATLIN, L., LIN, J. P., HOGUE, R., ESTRELLA, D., and FIERER, J. G. Lopez-Berestein and I. J. Fidler (Eds). UCLA (University of California-Los Angeles) Symposia on Molecular and Cellular Biology New Series, Vol. 89. Liposomes in the Therapy of Infectious Diseases and Cancer; Lake Tahoe, California, USA, February 16–20. 1988, 480 p, A. R. Liss, New York, NY, USA, publ. 1989, pp. 239–248.
  • Preparation of microencapsulated liposomes. YEUNG, V. W., and NIXON, J. R. J. Microencapsulation, 1988, 5, (4), 331–337.
  • Granuloma formation in mice by liposome-encapsulated glycolipid, `trehalose 2,3,6'-trimycolate'. YOKOI, F., SUGIMOTO, N., KATO, K., KANEDA, K., OKA, S., and YANO, I. Yakugaku Zasshi, 1989, 109, (1), 46–51.
  • Stimulation of trinitrophenyl (TNP)-specific T cell clone by liposomes carrying molecules from haptenated epidermal cells in contact sensitivity. YOKOZEKI, H., KATAYAMA, I., and NISHIOKA, K. Joint Meeting of the Society for Investigative Dermatology, European Society for Dermatologic Research, and Japanese Society for Investigative Dermatology, Washington, D.C., USA, April 26–30. 1989. Clin. Res., 1989, 37, (2), 656A.
  • Biopharmaceutical studies on zipeprol dihydrochloride microcapsules. YoNo, J. I., and KIM, 0. N. Yakche Hakhoechi, 1988, 18, (4), 187–195.
  • Effects of aluminum tristearate in the preparation of sustained release ethambutol hydrochloride microcapsules. Yoo, B. S. Yakche Hakhoechi, 1988, 18, (4), 175–180.
  • Targeted and sustained delivery of aclarubicin to lymphatics by lactic acid-oligomer microsphere in rat. YOSHIKAWA, H., NAKAO, Y TAKADA, K., MURANISHI, S., WADA, R., TABATA, Y., HYON, S. H., and IKADA, Y. Chem. Pharm. Bull., 1989, 37, (3), 802–804.
  • Experimental study of normal liver regeneration in hepatic arterial infusion with degradable starch microspheres (DSM). YOSHINAKA, K., KODAMA, H., SAEKI, T., KIN, T., JtNusul, K., TAKAGAMI, S., KIRIHARA, Y., NIIMOTO, M., and HATTORI, T. Gan To Kagaku Ryoho, 1989,16, (4, Pt. 1), 787–792.
  • Structure function studies of gramicidin S. II. Interaction between liposomes and highly bioactive gramicidin S analog lacking the two ornithine side chains. YOSFIITOMI, H., SHIMOHIGASHI, Y Oxo, S., WAKI, M., and INouE, T. Pept. Chem., 1989, 26, 317–320.
  • A new lymph node imaging agent-99mTc-polyphase liposome oleatis (99mTc-plo). Yu, B. F. Chung Hua Chung Liu Tsa Chih, 1988, 10, (4), 270–273.
  • Entrapping of hydrophobized plague capsular antigen into large unilamellar liposomes. ZAKREVSKII, V. I., PLEKHANOVA, N. G., and SMIRNOVA, V. I. Ukr. Biokhim. Zh., 1989, 61, (2), 89–93.
  • Responsiveness of the hamster pancreatic cancer to treatment with microcapsules of D-Trp-6-LH-RH and somatostatin analog RC-160. Histological evidence of improvement. ZALATNAI, A., and SCHALLY, A. V. Int. J. Pancreatol., 1989, 4, (2), 149–160.
  • Treatment of N-nitrosobis(2-oxopropyl)amine-induced pancreatic cancer in Syrian golden hamsters with D-Trp-6-LH-RH and somatostatin analogue RC-160 microcapsules. ZALATNAI, A., and SCHALLY, A. V. Cancer Res., 1989, 49, (7), 1810–1815.
  • Copolymerization of styrene with N-(tribromophenyl)maleimides and use of the copolymer in microencapsulation. ZAVERACH, M. M., KARATEEV, A. M., RILO, R. P., GOLOTENKO, S. N., and SAMOKHVALOV, E. P. Bromorgan Soed, Antipireny, 1988, 30–39.
  • Assessment of thrombogenic potential of liposornes. ZBINDEN, G., WUNDERLI-ALLENSPACH, H., and GRIMM, L. Toxicology, 1989, 54, (3), 273–280.
  • Treatment of wastewater containing chromate with microcapsules. ZHANG HEZHE, CHEN YAL/NG, and YAN ZHONG. Sep. Technol., Proc. Eng. Found. Conf., 2nd, 1987, Engineering Foundation, New York, NY, USA, publ. 1988, pp. 279–282. Eds: N. Li and H. Strathmann.
  • An ultrastructural comparative evaluation of tumors photosensitized by porphyrins administered in aqueous solution, bound to liposomes or to lipoproteins. ZHou, C. N., MILANESI, C., and JoRi, G. Photochem. Photobiol., 1988, 48, (4), 487–492.
  • Effects of liposome-coated nitrogen mustard on acute experimental serum sickness in rabbits. Zutou, F., and Zni, X. J. Med. Coll. PLA, 1988, 3, (3), 227–231.
  • Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. ZOCCHI, E., TONETTI, M., POLVANI, C., GUIDA, L., BENATTI, U., and DE-FLORA, A. Proc. Natl. Acad. Sci. USA, 1989, 86, (6), 2040–2044.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.